 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0080132	fatty acid alpha-hydroxylase activity	1	9.723874e-5	3.586165e-1	3.586165e-1	1.028397e+4	9.723874e-5	1	9.723874e-5	1.000000e+0	1	1.108586e-4	4.088465e-1	4.088465e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	FA2H
GO Molecular Function	GO:0020037	heme binding	2	8.778443e-3	1.000000e+0	1.000000e+0	1.139154e+2	8.778443e-3	1	8.778443e-3	1.000000e+0	2	1.425002e-2	1.000000e+0	1.000000e+0	6.992636e+1	1.430076e-2	1	129	5.000000e-1	7.751938e-3	unnamed	FA2H
GO Molecular Function	GO:0046906	tetrapyrrole binding	3	9.836374e-3	1.000000e+0	1.000000e+0	1.016635e+2	9.836374e-3	1	9.836374e-3	1.000000e+0	3	1.524040e-2	1.000000e+0	1.000000e+0	6.536594e+1	1.529849e-2	1	138	5.000000e-1	7.246377e-3	unnamed	FA2H
GO Molecular Function	GO:0005506	iron ion binding	4	1.254896e-2	1.000000e+0	1.000000e+0	7.968786e+1	1.254896e-2	1	1.254896e-2	1.000000e+0	4	1.776908e-2	1.000000e+0	1.000000e+0	5.602795e+1	1.784823e-2	1	161	5.000000e-1	6.211180e-3	unnamed	FA2H
GO Molecular Function	GO:0016491	oxidoreductase activity	5	6.045513e-2	1.000000e+0	1.000000e+0	1.654119e+1	6.045513e-2	1	6.045513e-2	1.000000e+0	5	7.769532e-2	1.000000e+0	1.000000e+0	1.261608e+1	7.926390e-2	1	715	5.000000e-1	1.398601e-3	unnamed	FA2H
GO Molecular Function	GO:0046914	transition metal ion binding	6	1.321251e-1	1.000000e+0	1.000000e+0	7.568583e+0	1.321251e-1	1	1.321251e-1	1.000000e+0	6	1.516365e-1	1.000000e+0	1.000000e+0	6.334621e+0	1.578626e-1	1	1424	5.000000e-1	7.022472e-4	unnamed	FA2H
GO Molecular Function	GO:0046872	metal ion binding	7	3.527991e-1	1.000000e+0	1.000000e+0	2.834474e+0	3.527991e-1	1	3.527991e-1	1.000000e+0	7	3.911753e-1	1.000000e+0	1.000000e+0	2.275605e+0	4.394435e-1	1	3964	5.000000e-1	2.522704e-4	unnamed	FA2H
GO Molecular Function	GO:0043169	cation binding	8	3.606111e-1	1.000000e+0	1.000000e+0	2.773071e+0	3.606111e-1	1	3.606111e-1	1.000000e+0	8	3.968711e-1	1.000000e+0	1.000000e+0	2.238337e+0	4.467602e-1	1	4030	5.000000e-1	2.481390e-4	unnamed	FA2H
GO Molecular Function	GO:1901363	heterocyclic compound binding	9	4.273925e-1	1.000000e+0	1.000000e+0	2.339769e+0	4.273925e-1	1	4.273925e-1	1.000000e+0	9	5.012582e-1	1.000000e+0	1.000000e+0	1.701981e+0	5.875506e-1	1	5300	5.000000e-1	1.886792e-4	unnamed	FA2H
GO Molecular Function	GO:0097159	organic cyclic compound binding	10	4.323803e-1	1.000000e+0	1.000000e+0	2.312779e+0	4.323803e-1	1	4.323803e-1	1.000000e+0	10	5.069571e-1	1.000000e+0	1.000000e+0	1.678857e+0	5.956433e-1	1	5373	5.000000e-1	1.861158e-4	unnamed	FA2H
GO Molecular Function	GO:0003824	catalytic activity	11	4.361959e-1	1.000000e+0	1.000000e+0	2.292548e+0	4.361959e-1	1	4.361959e-1	1.000000e+0	11	5.163312e-1	1.000000e+0	1.000000e+0	1.641882e+0	6.090571e-1	1	5494	5.000000e-1	1.820167e-4	unnamed	FA2H
GO Molecular Function	GO:0043167	ion binding	12	5.095070e-1	1.000000e+0	1.000000e+0	1.962682e+0	5.095070e-1	1	5.095070e-1	1.000000e+0	12	5.570694e-1	1.000000e+0	1.000000e+0	1.494945e+0	6.689208e-1	1	6034	5.000000e-1	1.657275e-4	unnamed	FA2H
GO Molecular Function	GO:0005488	binding	13	8.171102e-1	1.000000e+0	1.000000e+0	1.223825e+0	8.171102e-1	1	8.171102e-1	1.000000e+0	13	8.942547e-1	1.000000e+0	1.000000e+0	7.409644e-1	1.349593e+0	1	12174	5.000000e-1	8.214227e-5	unnamed	FA2H
GO Biological Process	GO:0001949	sebaceous gland cell differentiation	1	9.723874e-5	1.000000e+0	1.000000e+0	1.028397e+4	9.723874e-5	1	9.723874e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	FA2H
GO Biological Process	GO:0032286	central nervous system myelin maintenance	2	1.486676e-4	1.000000e+0	7.760449e-1	6.726414e+3	1.486676e-4	1	1.486676e-4	1.000000e+0	2	3.325574e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	FA2H
GO Biological Process	GO:0032287	peripheral nervous system myelin maintenance	3	5.084462e-4	1.000000e+0	1.000000e+0	1.966777e+3	5.084462e-4	1	5.084462e-4	1.000000e+0	4	7.758812e-4	1.000000e+0	1.000000e+0	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	FA2H
GO Biological Process	GO:0048733	sebaceous gland development	4	8.066335e-4	1.000000e+0	1.000000e+0	1.239720e+3	8.066335e-4	1	8.066335e-4	1.000000e+0	3	6.650594e-4	1.000000e+0	1.000000e+0	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	FA2H
GO Biological Process	GO:0043217	myelin maintenance	5	1.077257e-3	1.000000e+0	1.000000e+0	9.282840e+2	1.077257e-3	1	1.077257e-3	1.000000e+0	5	1.219107e-3	1.000000e+0	1.000000e+0	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	FA2H
GO Biological Process	GO:0022010	central nervous system myelination	6	1.709549e-3	1.000000e+0	1.000000e+0	5.849496e+2	1.709549e-3	1	1.709549e-3	1.000000e+0	6	1.440682e-3	1.000000e+0	1.000000e+0	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	FA2H
GO Biological Process	GO:0022011	myelination in peripheral nervous system	7	1.875382e-3	1.000000e+0	1.000000e+0	5.332246e+2	1.875382e-3	1	1.875382e-3	1.000000e+0	8	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	FA2H
GO Biological Process	GO:0014044	Schwann cell development	8	1.897433e-3	1.000000e+0	1.000000e+0	5.270280e+2	1.897433e-3	1	1.897433e-3	1.000000e+0	9	2.216004e-3	1.000000e+0	1.000000e+0	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	FA2H
GO Biological Process	GO:0042634	regulation of hair cycle	9	2.121444e-3	1.000000e+0	1.000000e+0	4.713770e+2	2.121444e-3	1	2.121444e-3	1.000000e+0	7	1.773000e-3	1.000000e+0	1.000000e+0	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	FA2H
GO Biological Process	GO:0014037	Schwann cell differentiation	10	2.365987e-3	1.000000e+0	1.000000e+0	4.226566e+2	2.365987e-3	1	2.365987e-3	1.000000e+0	10	2.880326e-3	1.000000e+0	1.000000e+0	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	FA2H
GO Biological Process	GO:0014003	oligodendrocyte development	11	4.590363e-3	1.000000e+0	1.000000e+0	2.178477e+2	4.590363e-3	1	4.590363e-3	1.000000e+0	11	3.544427e-3	1.000000e+0	1.000000e+0	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	FA2H
GO Biological Process	GO:0048709	oligodendrocyte differentiation	12	8.371421e-3	1.000000e+0	1.000000e+0	1.194540e+2	8.371421e-3	1	8.371421e-3	1.000000e+0	12	5.535402e-3	1.000000e+0	1.000000e+0	1.804100e+2	5.542930e-3	1	50	5.000000e-1	2.000000e-2	unnamed	FA2H
GO Biological Process	GO:0042552	myelination	13	9.063566e-3	1.000000e+0	1.000000e+0	1.103318e+2	9.063566e-3	1	9.063566e-3	1.000000e+0	14	8.407740e-3	1.000000e+0	1.000000e+0	1.186908e+2	8.425254e-3	1	76	5.000000e-1	1.315789e-2	unnamed	FA2H
GO Biological Process	GO:0008366	axon ensheathment	14	9.229419e-3	1.000000e+0	1.000000e+0	1.083492e+2	9.229419e-3	1	9.229419e-3	1.000000e+0	16	8.849269e-3	1.000000e+0	1.000000e+0	1.127562e+2	8.868688e-3	1	80	5.000000e-1	1.250000e-2	unnamed	FA2H
GO Biological Process	GO:0006633	fatty acid biosynthetic process	15	9.579437e-3	1.000000e+0	1.000000e+0	1.043903e+2	9.579437e-3	1	9.579437e-3	1.000000e+0	19	1.237796e-2	1.000000e+0	1.000000e+0	8.054018e+1	1.241616e-2	1	112	5.000000e-1	8.928571e-3	unnamed	FA2H
GO Biological Process	GO:0021782	glial cell development	16	9.855028e-3	1.000000e+0	1.000000e+0	1.014710e+2	9.855028e-3	1	9.855028e-3	1.000000e+0	13	7.855690e-3	1.000000e+0	1.000000e+0	1.270493e+2	7.870961e-3	1	71	5.000000e-1	1.408451e-2	unnamed	FA2H
GO Biological Process	GO:0007009	plasma membrane organization	17	1.009676e-2	1.000000e+0	1.000000e+0	9.904166e+1	1.009676e-2	1	1.009676e-2	1.000000e+0	18	1.193722e-2	1.000000e+0	1.000000e+0	8.352315e+1	1.197273e-2	1	108	5.000000e-1	9.259259e-3	unnamed	FA2H
GO Biological Process	GO:0006665	sphingolipid metabolic process	18	1.189857e-2	1.000000e+0	1.000000e+0	8.404370e+1	1.189857e-2	1	1.189857e-2	1.000000e+0	20	1.336928e-2	1.000000e+0	1.000000e+0	7.454959e+1	1.341389e-2	1	121	5.000000e-1	8.264463e-3	unnamed	FA2H
GO Biological Process	GO:0030258	lipid modification	19	1.212006e-2	1.000000e+0	1.000000e+0	8.250787e+1	1.212006e-2	1	1.212006e-2	1.000000e+0	22	1.358950e-2	1.000000e+0	1.000000e+0	7.333740e+1	1.363561e-2	1	123	5.000000e-1	8.130081e-3	unnamed	FA2H
GO Biological Process	GO:0019228	regulation of action potential in neuron	20	1.270586e-2	1.000000e+0	1.000000e+0	7.870385e+1	1.270586e-2	1	1.270586e-2	1.000000e+0	17	1.072467e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	97	5.000000e-1	1.030928e-2	unnamed	FA2H
GO Biological Process	GO:0007422	peripheral nervous system development	21	1.279933e-2	1.000000e+0	1.000000e+0	7.812908e+1	1.279933e-2	1	1.279933e-2	1.000000e+0	15	8.628517e-3	1.000000e+0	1.000000e+0	1.156474e+2	8.646971e-3	1	78	5.000000e-1	1.282051e-2	unnamed	FA2H
GO Biological Process	GO:0009913	epidermal cell differentiation	22	1.342847e-2	1.000000e+0	1.000000e+0	7.446863e+1	1.342847e-2	1	1.342847e-2	1.000000e+0	23	1.391979e-2	1.000000e+0	1.000000e+0	7.159127e+1	1.396818e-2	1	126	5.000000e-1	7.936508e-3	unnamed	FA2H
GO Biological Process	GO:0006643	membrane lipid metabolic process	23	1.399794e-2	1.000000e+0	1.000000e+0	7.143906e+1	1.399794e-2	1	1.399794e-2	1.000000e+0	26	1.776908e-2	1.000000e+0	1.000000e+0	5.602795e+1	1.784823e-2	1	161	5.000000e-1	6.211180e-3	unnamed	FA2H
GO Biological Process	GO:0072330	monocarboxylic acid biosynthetic process	24	1.463305e-2	1.000000e+0	1.000000e+0	6.833847e+1	1.463305e-2	1	1.463305e-2	1.000000e+0	27	1.809867e-2	1.000000e+0	1.000000e+0	5.500305e+1	1.818081e-2	1	164	5.000000e-1	6.097561e-3	unnamed	FA2H
GO Biological Process	GO:0010001	glial cell differentiation	25	2.025217e-2	1.000000e+0	1.000000e+0	4.937743e+1	2.025217e-2	1	2.025217e-2	1.000000e+0	20	1.336928e-2	1.000000e+0	1.000000e+0	7.454959e+1	1.341389e-2	1	121	5.000000e-1	8.264463e-3	unnamed	FA2H
GO Biological Process	GO:0001508	regulation of action potential	26	2.176549e-2	1.000000e+0	1.000000e+0	4.594430e+1	2.176549e-2	1	2.176549e-2	1.000000e+0	25	1.688991e-2	1.000000e+0	1.000000e+0	5.895752e+1	1.696137e-2	1	153	5.000000e-1	6.535948e-3	unnamed	FA2H
GO Biological Process	GO:0006631	fatty acid metabolic process	27	2.242543e-2	1.000000e+0	1.000000e+0	4.459223e+1	2.242543e-2	1	2.242543e-2	1.000000e+0	30	2.959946e-2	1.000000e+0	1.000000e+0	3.353346e+1	2.982096e-2	1	269	5.000000e-1	3.717472e-3	unnamed	FA2H
GO Biological Process	GO:0042063	gliogenesis	28	2.312132e-2	1.000000e+0	1.000000e+0	4.325013e+1	2.312132e-2	1	2.312132e-2	1.000000e+0	24	1.524040e-2	1.000000e+0	1.000000e+0	6.536594e+1	1.529849e-2	1	138	5.000000e-1	7.246377e-3	unnamed	FA2H
GO Biological Process	GO:0046394	carboxylic acid biosynthetic process	29	2.519210e-2	1.000000e+0	1.000000e+0	3.969498e+1	2.519210e-2	1	2.519210e-2	1.000000e+0	31	3.003624e-2	1.000000e+0	1.000000e+0	3.304212e+1	3.026440e-2	1	273	5.000000e-1	3.663004e-3	unnamed	FA2H
GO Biological Process	GO:0008544	epidermis development	30	2.845698e-2	1.000000e+0	1.000000e+0	3.514076e+1	2.845698e-2	1	2.845698e-2	1.000000e+0	28	2.708603e-2	1.000000e+0	1.000000e+0	3.666870e+1	2.727122e-2	1	246	5.000000e-1	4.065041e-3	unnamed	FA2H
GO Biological Process	GO:0043588	skin development	31	3.249392e-2	1.000000e+0	1.000000e+0	3.077499e+1	3.249392e-2	1	3.249392e-2	1.000000e+0	32	3.069123e-2	1.000000e+0	1.000000e+0	3.233154e+1	3.092955e-2	1	279	5.000000e-1	3.584229e-3	unnamed	FA2H
GO Biological Process	GO:0044283	small molecule biosynthetic process	32	3.466661e-2	1.000000e+0	1.000000e+0	2.884620e+1	3.466661e-2	1	3.466661e-2	1.000000e+0	34	4.309408e-2	1.000000e+0	1.000000e+0	2.295293e+1	4.356743e-2	1	393	5.000000e-1	2.544529e-3	unnamed	FA2H
GO Biological Process	GO:0032787	monocarboxylic acid metabolic process	33	3.578238e-2	1.000000e+0	1.000000e+0	2.794672e+1	3.578238e-2	1	3.578238e-2	1.000000e+0	36	4.558673e-2	1.000000e+0	1.000000e+0	2.168389e+1	4.611718e-2	1	416	5.000000e-1	2.403846e-3	unnamed	FA2H
GO Biological Process	GO:0044711	single-organism biosynthetic process	34	3.645402e-2	1.000000e+0	1.000000e+0	2.743181e+1	3.645402e-2	1	3.645402e-2	1.000000e+0	35	4.439500e-2	1.000000e+0	1.000000e+0	2.227284e+1	4.489773e-2	1	405	5.000000e-1	2.469136e-3	unnamed	FA2H
GO Biological Process	GO:0042391	regulation of membrane potential	35	4.092975e-2	1.000000e+0	1.000000e+0	2.443211e+1	4.092975e-2	1	4.092975e-2	1.000000e+0	33	3.210963e-2	1.000000e+0	1.000000e+0	3.089212e+1	3.237071e-2	1	292	5.000000e-1	3.424658e-3	unnamed	FA2H
GO Biological Process	GO:0008610	lipid biosynthetic process	36	4.482047e-2	1.000000e+0	1.000000e+0	2.231123e+1	4.482047e-2	1	4.482047e-2	1.000000e+0	38	5.390802e-2	1.000000e+0	1.000000e+0	1.829716e+1	5.465329e-2	1	493	5.000000e-1	2.028398e-3	unnamed	FA2H
GO Biological Process	GO:0044802	single-organism membrane organization	37	4.530897e-2	1.000000e+0	1.000000e+0	2.207068e+1	4.530897e-2	1	4.530897e-2	1.000000e+0	39	5.595572e-2	1.000000e+0	1.000000e+0	1.761816e+1	5.675960e-2	1	512	5.000000e-1	1.953125e-3	unnamed	FA2H
GO Biological Process	GO:0048732	gland development	38	4.607135e-2	1.000000e+0	1.000000e+0	2.170546e+1	4.607135e-2	1	4.607135e-2	1.000000e+0	29	2.927180e-2	1.000000e+0	1.000000e+0	3.391165e+1	2.948839e-2	1	266	5.000000e-1	3.759398e-3	unnamed	FA2H
GO Biological Process	GO:0061024	membrane organization	39	4.859662e-2	1.000000e+0	1.000000e+0	2.057756e+1	4.859662e-2	1	4.859662e-2	1.000000e+0	40	5.896934e-2	1.000000e+0	1.000000e+0	1.670463e+1	5.986364e-2	1	540	5.000000e-1	1.851852e-3	unnamed	FA2H
GO Biological Process	GO:0030855	epithelial cell differentiation	40	6.501472e-2	1.000000e+0	1.000000e+0	1.538113e+1	6.501472e-2	1	6.501472e-2	1.000000e+0	37	5.315304e-2	1.000000e+0	1.000000e+0	1.856070e+1	5.387728e-2	1	486	5.000000e-1	2.057613e-3	unnamed	FA2H
GO Biological Process	GO:0019752	carboxylic acid metabolic process	41	6.544102e-2	1.000000e+0	1.000000e+0	1.528093e+1	6.544102e-2	1	6.544102e-2	1.000000e+0	45	8.735845e-2	1.000000e+0	1.000000e+0	1.119169e+1	8.935203e-2	1	806	5.000000e-1	1.240695e-3	unnamed	FA2H
GO Biological Process	GO:0044255	cellular lipid metabolic process	42	7.113785e-2	1.000000e+0	1.000000e+0	1.405721e+1	7.113785e-2	1	7.113785e-2	1.000000e+0	46	8.894639e-2	1.000000e+0	1.000000e+0	1.098721e+1	9.101491e-2	1	821	5.000000e-1	1.218027e-3	unnamed	FA2H
GO Biological Process	GO:0055114	oxidation-reduction process	43	7.921377e-2	1.000000e+0	1.000000e+0	1.262407e+1	7.921377e-2	1	7.921377e-2	1.000000e+0	48	9.970771e-2	1.000000e+0	1.000000e+0	9.773023e+0	1.023225e-1	1	923	5.000000e-1	1.083424e-3	unnamed	FA2H
GO Biological Process	GO:0043436	oxoacid metabolic process	44	8.179018e-2	1.000000e+0	1.000000e+0	1.222641e+1	8.179018e-2	1	8.179018e-2	1.000000e+0	47	9.918168e-2	1.000000e+0	1.000000e+0	9.826253e+0	1.017682e-1	1	918	5.000000e-1	1.089325e-3	unnamed	FA2H
GO Biological Process	GO:0006082	organic acid metabolic process	45	8.296012e-2	1.000000e+0	1.000000e+0	1.205398e+1	8.296012e-2	1	8.296012e-2	1.000000e+0	49	1.008644e-1	1.000000e+0	1.000000e+0	9.657923e+0	1.035419e-1	1	934	5.000000e-1	1.070664e-3	unnamed	FA2H
GO Biological Process	GO:0006629	lipid metabolic process	46	9.193917e-2	1.000000e+0	1.000000e+0	1.087676e+1	9.193917e-2	1	9.193917e-2	1.000000e+0	50	1.144784e-1	1.000000e+0	1.000000e+0	8.477914e+0	1.179536e-1	1	1064	5.000000e-1	9.398496e-4	unnamed	FA2H
GO Biological Process	GO:0019226	transmission of nerve impulse	47	9.296328e-2	1.000000e+0	1.000000e+0	1.075694e+1	9.296328e-2	1	9.296328e-2	1.000000e+0	41	7.183029e-2	1.000000e+0	1.000000e+0	1.366742e+1	7.316668e-2	1	660	5.000000e-1	1.515152e-3	unnamed	FA2H
GO Biological Process	GO:0035637	multicellular organismal signaling	48	9.654494e-2	1.000000e+0	1.000000e+0	1.035787e+1	9.654494e-2	1	9.654494e-2	1.000000e+0	42	7.439186e-2	1.000000e+0	1.000000e+0	1.318787e+1	7.582728e-2	1	684	5.000000e-1	1.461988e-3	unnamed	FA2H
GO Biological Process	GO:0060429	epithelium development	49	1.052022e-1	1.000000e+0	1.000000e+0	9.505502e+0	1.052022e-1	1	1.052022e-1	1.000000e+0	44	8.269252e-2	1.000000e+0	1.000000e+0	1.183793e+1	8.447425e-2	1	762	5.000000e-1	1.312336e-3	unnamed	FA2H
GO Biological Process	GO:0008219	cell death	50	1.161348e-1	1.000000e+0	1.000000e+0	8.610686e+0	1.161348e-1	1	1.161348e-1	1.000000e+0	52	1.323311e-1	1.000000e+0	1.000000e+0	7.298139e+0	1.370212e-1	1	1236	5.000000e-1	8.090615e-4	unnamed	FA2H
GO Biological Process	GO:0016265	death	51	1.165949e-1	1.000000e+0	1.000000e+0	8.576703e+0	1.165949e-1	1	1.165949e-1	1.000000e+0	53	1.326408e-1	1.000000e+0	1.000000e+0	7.280468e+0	1.373538e-1	1	1239	5.000000e-1	8.071025e-4	unnamed	FA2H
GO Biological Process	GO:0007417	central nervous system development	52	1.166643e-1	1.000000e+0	1.000000e+0	8.571601e+0	1.166643e-1	1	1.166643e-1	1.000000e+0	43	7.865328e-2	1.000000e+0	1.000000e+0	1.245925e+1	8.026163e-2	1	724	5.000000e-1	1.381215e-3	unnamed	FA2H
GO Biological Process	GO:1901564	organonitrogen compound metabolic process	53	1.379740e-1	1.000000e+0	1.000000e+0	7.247740e+0	1.379740e-1	1	1.379740e-1	1.000000e+0	57	1.637442e-1	1.000000e+0	1.000000e+0	5.846079e+0	1.710548e-1	1	1543	5.000000e-1	6.480881e-4	unnamed	FA2H
GO Biological Process	GO:0042127	regulation of cell proliferation	54	1.497663e-1	1.000000e+0	1.000000e+0	6.677069e+0	1.497663e-1	1	1.497663e-1	1.000000e+0	54	1.334666e-1	1.000000e+0	1.000000e+0	7.233761e+0	1.382407e-1	1	1247	5.000000e-1	8.019246e-4	unnamed	FA2H
GO Biological Process	GO:0050877	neurological system process	55	1.566250e-1	1.000000e+0	1.000000e+0	6.384679e+0	1.566250e-1	1	1.566250e-1	1.000000e+0	58	1.641497e-1	1.000000e+0	1.000000e+0	5.830963e+0	1.714983e-1	1	1547	5.000000e-1	6.464124e-4	unnamed	FA2H
GO Biological Process	GO:0009888	tissue development	56	1.692045e-1	1.000000e+0	1.000000e+0	5.910010e+0	1.692045e-1	1	1.692045e-1	1.000000e+0	56	1.422163e-1	1.000000e+0	1.000000e+0	6.772147e+0	1.476637e-1	1	1332	5.000000e-1	7.507508e-4	unnamed	FA2H
GO Biological Process	GO:0022008	neurogenesis	57	1.821770e-1	1.000000e+0	1.000000e+0	5.489167e+0	1.821770e-1	1	1.821770e-1	1.000000e+0	51	1.310914e-1	1.000000e+0	1.000000e+0	7.369690e+0	1.356909e-1	1	1224	5.000000e-1	8.169935e-4	unnamed	FA2H
GO Biological Process	GO:0048468	cell development	58	1.837839e-1	1.000000e+0	1.000000e+0	5.441172e+0	1.837839e-1	1	1.837839e-1	1.000000e+0	55	1.403671e-1	1.000000e+0	1.000000e+0	6.864916e+0	1.456682e-1	1	1314	5.000000e-1	7.610350e-4	unnamed	FA2H
GO Biological Process	GO:0003008	system process	59	1.967197e-1	1.000000e+0	1.000000e+0	5.083376e+0	1.967197e-1	1	1.967197e-1	1.000000e+0	60	2.046945e-1	1.000000e+0	1.000000e+0	4.621158e+0	2.163960e-1	1	1952	5.000000e-1	5.122951e-4	unnamed	FA2H
GO Biological Process	GO:0044281	small molecule metabolic process	60	2.001784e-1	1.000000e+0	1.000000e+0	4.995545e+0	2.001784e-1	1	2.001784e-1	1.000000e+0	63	2.509628e-1	1.000000e+0	1.000000e+0	3.716728e+0	2.690538e-1	1	2427	5.000000e-1	4.120313e-4	unnamed	FA2H
GO Biological Process	GO:0051239	regulation of multicellular organismal process	61	2.372698e-1	1.000000e+0	1.000000e+0	4.214612e+0	2.372698e-1	1	2.372698e-1	1.000000e+0	61	2.076578e-1	1.000000e+0	1.000000e+0	4.551211e+0	2.197217e-1	1	1982	5.000000e-1	5.045409e-4	unnamed	FA2H
GO Biological Process	GO:0007399	nervous system development	62	2.488754e-1	1.000000e+0	1.000000e+0	4.018075e+0	2.488754e-1	1	2.488754e-1	1.000000e+0	59	1.894961e-1	1.000000e+0	1.000000e+0	5.014175e+0	1.994346e-1	1	1799	5.000000e-1	5.558644e-4	unnamed	FA2H
GO Biological Process	GO:0044710	single-organism metabolic process	63	2.517961e-1	1.000000e+0	1.000000e+0	3.971468e+0	2.517961e-1	1	2.517961e-1	1.000000e+0	67	3.105584e-1	1.000000e+0	1.000000e+0	2.946913e+0	3.393382e-1	1	3061	5.000000e-1	3.266906e-4	unnamed	FA2H
GO Biological Process	GO:0065008	regulation of biological quality	64	2.713082e-1	1.000000e+0	1.000000e+0	3.685845e+0	2.713082e-1	1	2.713082e-1	1.000000e+0	66	2.887566e-1	1.000000e+0	1.000000e+0	3.191967e+0	3.132864e-1	1	2826	5.000000e-1	3.538570e-4	unnamed	FA2H
GO Biological Process	GO:0048513	organ development	65	2.824258e-1	1.000000e+0	1.000000e+0	3.540753e+0	2.824258e-1	1	2.824258e-1	1.000000e+0	62	2.446169e-1	1.000000e+0	1.000000e+0	3.820627e+0	2.617372e-1	1	2361	5.000000e-1	4.235493e-4	unnamed	FA2H
GO Biological Process	GO:0030154	cell differentiation	66	3.160741e-1	1.000000e+0	1.000000e+0	3.163815e+0	3.160741e-1	1	3.160741e-1	1.000000e+0	64	2.690819e-1	1.000000e+0	1.000000e+0	3.446886e+0	2.901170e-1	1	2617	5.000000e-1	3.821169e-4	unnamed	FA2H
GO Biological Process	GO:0048869	cellular developmental process	67	3.225257e-1	1.000000e+0	1.000000e+0	3.100528e+0	3.225257e-1	1	3.225257e-1	1.000000e+0	65	2.802231e-1	1.000000e+0	1.000000e+0	3.298172e+0	3.031983e-1	1	2735	5.000000e-1	3.656307e-4	unnamed	FA2H
GO Biological Process	GO:0044249	cellular biosynthetic process	68	3.470471e-1	1.000000e+0	1.000000e+0	2.881453e+0	3.470471e-1	1	3.470471e-1	1.000000e+0	73	4.041671e-1	1.000000e+0	1.000000e+0	2.192102e+0	4.561831e-1	1	4115	5.000000e-1	2.430134e-4	unnamed	FA2H
GO Biological Process	GO:1901576	organic substance biosynthetic process	69	3.536536e-1	1.000000e+0	1.000000e+0	2.827626e+0	3.536536e-1	1	3.536536e-1	1.000000e+0	75	4.118439e-1	1.000000e+0	1.000000e+0	2.145184e+0	4.661604e-1	1	4205	5.000000e-1	2.378121e-4	unnamed	FA2H
GO Biological Process	GO:0009058	biosynthetic process	70	3.586722e-1	1.000000e+0	1.000000e+0	2.788061e+0	3.586722e-1	1	3.586722e-1	1.000000e+0	76	4.178650e-1	1.000000e+0	1.000000e+0	2.109565e+0	4.740314e-1	1	4276	5.000000e-1	2.338634e-4	unnamed	FA2H
GO Biological Process	GO:0044767	single-organism developmental process	71	3.730678e-1	1.000000e+0	1.000000e+0	2.680478e+0	3.730678e-1	1	3.730678e-1	1.000000e+0	68	3.331076e-1	1.000000e+0	1.000000e+0	2.726874e+0	3.667202e-1	1	3308	5.000000e-1	3.022975e-4	unnamed	FA2H
GO Biological Process	GO:0016043	cellular component organization	72	3.831577e-1	1.000000e+0	1.000000e+0	2.609891e+0	3.831577e-1	1	3.831577e-1	1.000000e+0	72	3.965267e-1	1.000000e+0	1.000000e+0	2.240561e+0	4.463167e-1	1	4026	5.000000e-1	2.483855e-4	unnamed	FA2H
GO Biological Process	GO:0071840	cellular component organization or biogenesis	73	3.897194e-1	1.000000e+0	1.000000e+0	2.565949e+0	3.897194e-1	1	3.897194e-1	1.000000e+0	74	4.070731e-1	1.000000e+0	1.000000e+0	2.174138e+0	4.599523e-1	1	4149	5.000000e-1	2.410219e-4	unnamed	FA2H
GO Biological Process	GO:0048731	system development	74	3.900631e-1	1.000000e+0	1.000000e+0	2.563688e+0	3.900631e-1	1	3.900631e-1	1.000000e+0	69	3.405107e-1	1.000000e+0	1.000000e+0	2.660914e+0	3.758107e-1	1	3390	5.000000e-1	2.949853e-4	unnamed	FA2H
GO Biological Process	GO:0006807	nitrogen compound metabolic process	75	4.138051e-1	1.000000e+0	1.000000e+0	2.416597e+0	4.138051e-1	1	4.138051e-1	1.000000e+0	80	4.994558e-1	1.000000e+0	1.000000e+0	1.709399e+0	5.850008e-1	1	5277	5.000000e-1	1.895016e-4	unnamed	FA2H
GO Biological Process	GO:0048856	anatomical structure development	76	4.234725e-1	1.000000e+0	1.000000e+0	2.361429e+0	4.234725e-1	1	4.234725e-1	1.000000e+0	70	3.845834e-1	1.000000e+0	1.000000e+0	2.320087e+0	4.310182e-1	1	3888	5.000000e-1	2.572016e-4	unnamed	FA2H
GO Biological Process	GO:0007275	multicellular organismal development	77	4.357034e-1	1.000000e+0	1.000000e+0	2.295139e+0	4.357034e-1	1	4.357034e-1	1.000000e+0	71	3.919536e-1	1.000000e+0	1.000000e+0	2.270451e+0	4.404412e-1	1	3973	5.000000e-1	2.516990e-4	unnamed	FA2H
GO Biological Process	GO:0044700	single organism signaling	78	4.371810e-1	1.000000e+0	1.000000e+0	2.287382e+0	4.371810e-1	1	4.371810e-1	1.000000e+0	78	4.576762e-1	1.000000e+0	1.000000e+0	1.897056e+0	5.271326e-1	1	4755	5.000000e-1	2.103049e-4	unnamed	FA2H
GO Biological Process	GO:0007154	cell communication	79	4.446638e-1	1.000000e+0	1.000000e+0	2.248890e+0	4.446638e-1	1	4.446638e-1	1.000000e+0	79	4.676716e-1	1.000000e+0	1.000000e+0	1.849221e+0	5.407683e-1	1	4878	5.000000e-1	2.050021e-4	unnamed	FA2H
GO Biological Process	GO:0032502	developmental process	80	4.657420e-1	1.000000e+0	1.000000e+0	2.147111e+0	4.657420e-1	1	4.657420e-1	1.000000e+0	77	4.306509e-1	1.000000e+0	1.000000e+0	2.037150e+0	4.908819e-1	1	4428	5.000000e-1	2.258356e-4	unnamed	FA2H
GO Biological Process	GO:0044707	single-multicellular organism process	81	5.372858e-1	1.000000e+0	1.000000e+0	1.861207e+0	5.372858e-1	1	5.372858e-1	1.000000e+0	81	5.291973e-1	1.000000e+0	1.000000e+0	1.593165e+0	6.276814e-1	1	5662	5.000000e-1	1.766160e-4	unnamed	FA2H
GO Biological Process	GO:0032501	multicellular organismal process	82	5.539872e-1	1.000000e+0	1.000000e+0	1.805096e+0	5.539872e-1	1	5.539872e-1	1.000000e+0	82	5.461571e-1	1.000000e+0	1.000000e+0	1.532275e+0	6.526246e-1	1	5887	5.000000e-1	1.698658e-4	unnamed	FA2H
GO Biological Process	GO:0044237	cellular metabolic process	83	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	83	7.045181e-1	1.000000e+0	1.000000e+0	1.095519e+0	9.128097e-1	1	8234	5.000000e-1	1.214477e-4	unnamed	FA2H
GO Biological Process	GO:0044238	primary metabolic process	84	6.053666e-1	1.000000e+0	1.000000e+0	1.651892e+0	6.053666e-1	1	6.053666e-1	1.000000e+0	84	7.093792e-1	1.000000e+0	1.000000e+0	1.084847e+0	9.217893e-1	1	8315	5.000000e-1	1.202646e-4	unnamed	FA2H
GO Biological Process	GO:0071704	organic substance metabolic process	85	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	85	7.239536e-1	1.000000e+0	1.000000e+0	1.053551e+0	9.491713e-1	1	8562	5.000000e-1	1.167951e-4	unnamed	FA2H
GO Biological Process	GO:0008152	metabolic process	86	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	87	7.596471e-1	1.000000e+0	1.000000e+0	9.809156e-1	1.019456e+0	1	9196	5.000000e-1	1.087429e-4	unnamed	FA2H
GO Biological Process	GO:0050794	regulation of cellular process	87	6.759845e-1	1.000000e+0	1.000000e+0	1.479324e+0	6.759845e-1	1	6.759845e-1	1.000000e+0	86	7.406997e-1	1.000000e+0	1.000000e+0	1.018805e+0	9.815420e-1	1	8854	5.000000e-1	1.129433e-4	unnamed	FA2H
GO Biological Process	GO:0050789	regulation of biological process	88	6.921477e-1	1.000000e+0	1.000000e+0	1.444778e+0	6.921477e-1	1	6.921477e-1	1.000000e+0	88	7.668214e-1	1.000000e+0	1.000000e+0	9.669311e-1	1.034200e+0	1	9329	5.000000e-1	1.071926e-4	unnamed	FA2H
GO Biological Process	GO:0065007	biological regulation	89	7.151977e-1	1.000000e+0	1.000000e+0	1.398215e+0	7.151977e-1	1	7.151977e-1	1.000000e+0	89	7.940293e-1	1.000000e+0	1.000000e+0	9.155080e-1	1.092290e+0	1	9853	5.000000e-1	1.014919e-4	unnamed	FA2H
GO Biological Process	GO:0044763	single-organism cellular process	90	7.497126e-1	1.000000e+0	1.000000e+0	1.333844e+0	7.497126e-1	1	7.497126e-1	1.000000e+0	90	8.068544e-1	1.000000e+0	1.000000e+0	8.920589e-1	1.121002e+0	1	10112	5.000000e-1	9.889241e-5	unnamed	FA2H
GO Biological Process	GO:0044699	single-organism process	91	7.935590e-1	1.000000e+0	1.000000e+0	1.260146e+0	7.935590e-1	1	7.935590e-1	1.000000e+0	91	8.529291e-1	1.000000e+0	1.000000e+0	8.110502e-1	1.232969e+0	1	11122	5.000000e-1	8.991189e-5	unnamed	FA2H
GO Biological Process	GO:0009987	cellular process	92	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	92	9.369062e-1	1.000000e+0	1.000000e+0	6.677400e-1	1.497589e+0	1	13509	5.000000e-1	7.402472e-5	unnamed	FA2H
GO Cellular Component	GO:0005789	endoplasmic reticulum membrane	1	6.490642e-2	1.000000e+0	1.000000e+0	1.540680e+1	6.490642e-2	1	6.490642e-2	1.000000e+0	1	8.534508e-2	1.000000e+0	1.000000e+0	1.146188e+1	8.724572e-2	1	787	5.000000e-1	1.270648e-3	unnamed	FA2H
GO Cellular Component	GO:0042175	nuclear outer membrane-endoplasmic reticulum membrane network	2	6.714499e-2	1.000000e+0	1.000000e+0	1.489314e+1	6.714499e-2	1	6.714499e-2	1.000000e+0	2	8.735845e-2	1.000000e+0	1.000000e+0	1.119169e+1	8.935203e-2	1	806	5.000000e-1	1.240695e-3	unnamed	FA2H
GO Cellular Component	GO:0044432	endoplasmic reticulum part	3	7.857548e-2	1.000000e+0	1.000000e+0	1.272662e+1	7.857548e-2	1	7.857548e-2	1.000000e+0	3	1.014950e-1	1.000000e+0	1.000000e+0	9.596277e+0	1.042071e-1	1	940	5.000000e-1	1.063830e-3	unnamed	FA2H
GO Cellular Component	GO:0005783	endoplasmic reticulum	4	1.167593e-1	1.000000e+0	1.000000e+0	8.564628e+0	1.167593e-1	1	1.167593e-1	1.000000e+0	4	1.436532e-1	1.000000e+0	1.000000e+0	6.701709e+0	1.492157e-1	1	1346	5.000000e-1	7.429421e-4	unnamed	FA2H
GO Cellular Component	GO:0012505	endomembrane system	5	1.513815e-1	1.000000e+0	1.000000e+0	6.605825e+0	1.513815e-1	1	1.513815e-1	1.000000e+0	5	1.741537e-1	1.000000e+0	1.000000e+0	5.480255e+0	1.824733e-1	1	1646	5.000000e-1	6.075334e-4	unnamed	FA2H
GO Cellular Component	GO:0031090	organelle membrane	6	2.131131e-1	1.000000e+0	1.000000e+0	4.692344e+0	2.131131e-1	1	2.131131e-1	1.000000e+0	6	2.650007e-1	1.000000e+0	1.000000e+0	3.504468e+0	2.853500e-1	1	2574	5.000000e-1	3.885004e-4	unnamed	FA2H
GO Cellular Component	GO:0016021	integral to membrane	7	4.578656e-1	1.000000e+0	1.000000e+0	2.184047e+0	4.578656e-1	1	4.578656e-1	1.000000e+0	7	4.982001e-1	1.000000e+0	1.000000e+0	1.714598e+0	5.832271e-1	1	5261	5.000000e-1	1.900779e-4	unnamed	FA2H
GO Cellular Component	GO:0031224	intrinsic to membrane	8	4.694206e-1	1.000000e+0	1.000000e+0	2.130286e+0	4.694206e-1	1	4.694206e-1	1.000000e+0	8	5.070350e-1	1.000000e+0	1.000000e+0	1.678545e+0	5.957541e-1	1	5374	5.000000e-1	1.860811e-4	unnamed	FA2H
GO Cellular Component	GO:0044446	intracellular organelle part	9	4.732075e-1	1.000000e+0	1.000000e+0	2.113238e+0	4.732075e-1	1	4.732075e-1	1.000000e+0	10	5.897910e-1	1.000000e+0	1.000000e+0	1.390765e+0	7.190289e-1	1	6486	5.000000e-1	1.541782e-4	unnamed	FA2H
GO Cellular Component	GO:0044422	organelle part	10	4.814989e-1	1.000000e+0	1.000000e+0	2.076848e+0	4.814989e-1	1	4.814989e-1	1.000000e+0	11	5.977049e-1	1.000000e+0	1.000000e+0	1.367157e+0	7.314450e-1	1	6598	5.000000e-1	1.515611e-4	unnamed	FA2H
GO Cellular Component	GO:0044444	cytoplasmic part	11	5.199381e-1	1.000000e+0	1.000000e+0	1.923306e+0	5.199381e-1	1	5.199381e-1	1.000000e+0	12	6.277110e-1	1.000000e+0	1.000000e+0	1.282596e+0	7.796685e-1	1	7033	5.000000e-1	1.421868e-4	unnamed	FA2H
GO Cellular Component	GO:0044425	membrane part	12	5.293034e-1	1.000000e+0	1.000000e+0	1.889276e+0	5.293034e-1	1	5.293034e-1	1.000000e+0	9	5.687230e-1	1.000000e+0	1.000000e+0	1.456564e+0	6.865473e-1	1	6193	5.000000e-1	1.614726e-4	unnamed	FA2H
GO Cellular Component	GO:0016020	membrane	13	6.308744e-1	1.000000e+0	1.000000e+0	1.585102e+0	6.308744e-1	1	6.308744e-1	1.000000e+0	13	6.811747e-1	1.000000e+0	1.000000e+0	1.148523e+0	8.706834e-1	1	7854	5.000000e-1	1.273237e-4	unnamed	FA2H
GO Cellular Component	GO:0005737	cytoplasm	14	6.734732e-1	1.000000e+0	1.000000e+0	1.484840e+0	6.734732e-1	1	6.734732e-1	1.000000e+0	14	7.735178e-1	1.000000e+0	1.000000e+0	9.540455e-1	1.048168e+0	1	9455	5.000000e-1	1.057641e-4	unnamed	FA2H
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	15	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	15	8.019514e-1	1.000000e+0	1.000000e+0	9.009688e-1	1.109916e+0	1	10012	5.000000e-1	9.988014e-5	unnamed	FA2H
GO Cellular Component	GO:0043227	membrane-bounded organelle	16	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	16	8.036253e-1	1.000000e+0	1.000000e+0	8.979196e-1	1.113685e+0	1	10046	5.000000e-1	9.954211e-5	unnamed	FA2H
GO Cellular Component	GO:0043229	intracellular organelle	17	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	17	8.473502e-1	1.000000e+0	1.000000e+0	8.206423e-1	1.218558e+0	1	10992	5.000000e-1	9.097525e-5	unnamed	FA2H
GO Cellular Component	GO:0043226	organelle	18	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	18	8.487331e-1	1.000000e+0	1.000000e+0	8.182602e-1	1.222105e+0	1	11024	5.000000e-1	9.071118e-5	unnamed	FA2H
GO Cellular Component	GO:0044424	intracellular part	19	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	19	9.083176e-1	1.000000e+0	1.000000e+0	7.171649e-1	1.394379e+0	1	12578	5.000000e-1	7.950390e-5	unnamed	FA2H
GO Cellular Component	GO:0005622	intracellular	20	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	20	9.139354e-1	1.000000e+0	1.000000e+0	7.076012e-1	1.413225e+0	1	12748	5.000000e-1	7.844368e-5	unnamed	FA2H
GO Cellular Component	GO:0044464	cell part	21	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	21	9.677154e-1	1.000000e+0	1.000000e+0	6.095344e-1	1.640596e+0	1	14799	5.000000e-1	6.757213e-5	unnamed	FA2H
GO Cellular Component	GO:0005623	cell	22	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	22	9.677354e-1	1.000000e+0	1.000000e+0	6.094932e-1	1.640707e+0	1	14800	5.000000e-1	6.756757e-5	unnamed	FA2H
Mouse Phenotype	MP:0003871	abnormal myelin sheath morphology	1	6.774241e-3	1.000000e+0	1.000000e+0	1.476180e+2	6.774241e-3	1	6.774241e-3	1.000000e+0	2	7.524386e-3	1.000000e+0	1.000000e+0	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	FA2H
Mouse Phenotype	MP:0002804	abnormal motor learning	2	7.524151e-3	1.000000e+0	1.000000e+0	1.329054e+2	7.524151e-3	1	7.524151e-3	1.000000e+0	1	5.203711e-3	1.000000e+0	1.000000e+0	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	FA2H
Mouse Phenotype	MP:0000755	hindlimb paralysis	3	9.636514e-3	1.000000e+0	1.000000e+0	1.037720e+2	9.636514e-3	1	9.636514e-3	1.000000e+0	3	8.959636e-3	1.000000e+0	1.000000e+0	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	FA2H
Mouse Phenotype	MP:0000921	demyelination	4	1.000427e-2	1.000000e+0	1.000000e+0	9.995731e+1	1.000427e-2	1	1.000427e-2	1.000000e+0	4	9.842351e-3	1.000000e+0	1.000000e+0	1.013539e+2	9.866415e-3	1	89	5.000000e-1	1.123596e-2	unnamed	FA2H
Mouse Phenotype	MP:0002757	decreased vertical activity	5	1.324291e-2	1.000000e+0	1.000000e+0	7.551208e+1	1.324291e-2	1	1.324291e-2	1.000000e+0	6	1.369960e-2	1.000000e+0	1.000000e+0	7.274597e+1	1.374647e-2	1	124	5.000000e-1	8.064516e-3	unnamed	FA2H
Mouse Phenotype	MP:0000753	paralysis	6	1.521776e-2	1.000000e+0	1.000000e+0	6.571271e+1	1.521776e-2	1	1.521776e-2	1.000000e+0	7	1.402987e-2	1.000000e+0	1.000000e+0	7.102756e+1	1.407904e-2	1	127	5.000000e-1	7.874016e-3	unnamed	FA2H
Mouse Phenotype	MP:0002182	abnormal astrocyte morphology	7	1.662627e-2	1.000000e+0	1.000000e+0	6.014579e+1	1.662627e-2	1	1.662627e-2	1.000000e+0	8	1.721965e-2	1.000000e+0	1.000000e+0	5.782372e+1	1.729394e-2	1	156	5.000000e-1	6.410256e-3	unnamed	FA2H
Mouse Phenotype	MP:0001330	abnormal optic nerve morphology	8	1.750390e-2	1.000000e+0	1.000000e+0	5.713013e+1	1.750390e-2	1	1.750390e-2	1.000000e+0	5	1.127592e-2	1.000000e+0	1.000000e+0	8.843627e+1	1.130758e-2	1	102	5.000000e-1	9.803922e-3	unnamed	FA2H
Mouse Phenotype	MP:0003983	decreased cholesterol level	9	1.946532e-2	1.000000e+0	1.000000e+0	5.137342e+1	1.946532e-2	1	1.946532e-2	1.000000e+0	14	2.325502e-2	1.000000e+0	1.000000e+0	4.275118e+1	2.339116e-2	1	211	5.000000e-1	4.739336e-3	unnamed	FA2H
Mouse Phenotype	MP:0000920	abnormal myelination	10	2.196541e-2	1.000000e+0	1.000000e+0	4.552613e+1	2.196541e-2	1	2.196541e-2	1.000000e+0	9	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	FA2H
Mouse Phenotype	MP:0005404	abnormal axon morphology	11	2.479127e-2	1.000000e+0	1.000000e+0	4.033678e+1	2.479127e-2	1	2.479127e-2	1.000000e+0	10	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	FA2H
Mouse Phenotype	MP:0000877	abnormal Purkinje cell morphology	12	2.502270e-2	1.000000e+0	1.000000e+0	3.996371e+1	2.502270e-2	1	2.502270e-2	1.000000e+0	11	2.226868e-2	1.000000e+0	1.000000e+0	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	FA2H
Mouse Phenotype	MP:0000875	abnormal cerebellar Purkinje cell layer	13	2.920911e-2	1.000000e+0	1.000000e+0	3.423590e+1	2.920911e-2	1	2.920911e-2	1.000000e+0	15	2.478833e-2	1.000000e+0	1.000000e+0	4.009111e+1	2.494318e-2	1	225	5.000000e-1	4.444444e-3	unnamed	FA2H
Mouse Phenotype	MP:0001463	abnormal spatial learning	14	3.098486e-2	1.000000e+0	1.000000e+0	3.227383e+1	3.098486e-2	1	3.098486e-2	1.000000e+0	12	2.281671e-2	1.000000e+0	1.000000e+0	4.357729e+1	2.294773e-2	1	207	5.000000e-1	4.830918e-3	unnamed	FA2H
Mouse Phenotype	MP:0000952	abnormal CNS glial cell morphology	15	3.199709e-2	1.000000e+0	1.000000e+0	3.125284e+1	3.199709e-2	1	3.199709e-2	1.000000e+0	16	2.894409e-2	1.000000e+0	1.000000e+0	3.429848e+1	2.915581e-2	1	263	5.000000e-1	3.802281e-3	unnamed	FA2H
Mouse Phenotype	MP:0001056	abnormal cranial nerve morphology	16	3.400276e-2	1.000000e+0	1.000000e+0	2.940938e+1	3.400276e-2	1	3.400276e-2	1.000000e+0	13	2.314545e-2	1.000000e+0	1.000000e+0	4.295476e+1	2.328031e-2	1	210	5.000000e-1	4.761905e-3	unnamed	FA2H
Mouse Phenotype	MP:0003947	abnormal cholesterol level	17	3.633886e-2	1.000000e+0	1.000000e+0	2.751875e+1	3.633886e-2	1	3.633886e-2	1.000000e+0	23	4.179228e-2	1.000000e+0	1.000000e+0	2.367585e+1	4.223713e-2	1	381	5.000000e-1	2.624672e-3	unnamed	FA2H
Mouse Phenotype	MP:0009956	abnormal cerebellar layer morphology	18	3.723440e-2	1.000000e+0	1.000000e+0	2.685689e+1	3.723440e-2	1	3.723440e-2	1.000000e+0	17	2.981786e-2	1.000000e+0	1.000000e+0	3.328598e+1	3.004268e-2	1	271	5.000000e-1	3.690037e-3	unnamed	FA2H
Mouse Phenotype	MP:0005278	abnormal cholesterol homeostasis	19	3.725956e-2	1.000000e+0	1.000000e+0	2.683875e+1	3.725956e-2	1	3.725956e-2	1.000000e+0	25	4.255177e-2	1.000000e+0	1.000000e+0	2.324871e+1	4.301314e-2	1	388	5.000000e-1	2.577320e-3	unnamed	FA2H
Mouse Phenotype	MP:0012224	abnormal sterol level	20	3.799903e-2	1.000000e+0	1.000000e+0	2.631646e+1	3.799903e-2	1	3.799903e-2	1.000000e+0	26	4.352782e-2	1.000000e+0	1.000000e+0	2.272166e+1	4.401086e-2	1	397	5.000000e-1	2.518892e-3	unnamed	FA2H
Mouse Phenotype	MP:0003634	abnormal glial cell morphology	21	4.227551e-2	1.000000e+0	1.000000e+0	2.365436e+1	4.227551e-2	1	4.227551e-2	1.000000e+0	20	3.831648e-2	1.000000e+0	1.000000e+0	2.584670e+1	3.868965e-2	1	349	5.000000e-1	2.865330e-3	unnamed	FA2H
Mouse Phenotype	MP:0004097	abnormal cerebellar cortex morphology	22	4.448801e-2	1.000000e+0	1.000000e+0	2.247797e+1	4.448801e-2	1	4.448801e-2	1.000000e+0	18	3.363597e-2	1.000000e+0	1.000000e+0	2.947876e+1	3.392273e-2	1	306	5.000000e-1	3.267974e-3	unnamed	FA2H
Mouse Phenotype	MP:0008415	abnormal neurite morphology	23	4.858697e-2	1.000000e+0	1.000000e+0	2.058165e+1	4.858697e-2	1	4.858697e-2	1.000000e+0	19	3.712022e-2	1.000000e+0	1.000000e+0	2.668787e+1	3.747021e-2	1	338	5.000000e-1	2.958580e-3	unnamed	FA2H
Mouse Phenotype	MP:0001402	hypoactivity	24	5.204776e-2	1.000000e+0	1.000000e+0	1.921312e+1	5.204776e-2	1	5.204776e-2	1.000000e+0	22	4.168376e-2	1.000000e+0	1.000000e+0	2.373816e+1	4.212627e-2	1	380	5.000000e-1	2.631579e-3	unnamed	FA2H
Mouse Phenotype	MP:0001405	impaired coordination	25	5.271387e-2	1.000000e+0	1.000000e+0	1.897034e+1	5.271387e-2	1	5.271387e-2	1.000000e+0	21	4.059818e-2	1.000000e+0	1.000000e+0	2.437973e+1	4.101768e-2	1	370	5.000000e-1	2.702703e-3	unnamed	FA2H
Mouse Phenotype	MP:0000849	abnormal cerebellum morphology	26	5.650568e-2	1.000000e+0	1.000000e+0	1.769734e+1	5.650568e-2	1	5.650568e-2	1.000000e+0	24	4.190080e-2	1.000000e+0	1.000000e+0	2.361387e+1	4.234799e-2	1	382	5.000000e-1	2.617801e-3	unnamed	FA2H
Mouse Phenotype	MP:0000847	abnormal metencephalon morphology	27	6.041658e-2	1.000000e+0	1.000000e+0	1.655175e+1	6.041658e-2	1	6.041658e-2	1.000000e+0	27	4.504512e-2	1.000000e+0	1.000000e+0	2.194769e+1	4.556288e-2	1	411	5.000000e-1	2.433090e-3	unnamed	FA2H
Mouse Phenotype	MP:0000841	abnormal hindbrain morphology	28	6.658160e-2	1.000000e+0	1.000000e+0	1.501917e+1	6.658160e-2	1	6.658160e-2	1.000000e+0	28	5.013013e-2	1.000000e+0	1.000000e+0	1.969541e+1	5.077324e-2	1	458	5.000000e-1	2.183406e-3	unnamed	FA2H
Mouse Phenotype	MP:0005195	abnormal posterior eye segment morphology	29	7.618498e-2	1.000000e+0	1.000000e+0	1.312595e+1	7.618498e-2	1	7.618498e-2	1.000000e+0	30	6.262226e-2	1.000000e+0	1.000000e+0	1.571516e+1	6.363284e-2	1	574	5.000000e-1	1.742160e-3	unnamed	FA2H
Mouse Phenotype	MP:0001547	abnormal lipid level	30	7.658706e-2	1.000000e+0	1.000000e+0	1.305704e+1	7.658706e-2	1	7.658706e-2	1.000000e+0	32	8.322334e-2	1.000000e+0	1.000000e+0	1.176076e+1	8.502855e-2	1	767	5.000000e-1	1.303781e-3	unnamed	FA2H
Mouse Phenotype	MP:0002063	abnormal learning/memory/conditioning	31	7.681964e-2	1.000000e+0	1.000000e+0	1.301750e+1	7.681964e-2	1	7.681964e-2	1.000000e+0	29	5.821639e-2	1.000000e+0	1.000000e+0	1.692402e+1	5.908763e-2	1	533	5.000000e-1	1.876173e-3	unnamed	FA2H
Mouse Phenotype	MP:0002118	abnormal lipid homeostasis	32	8.181450e-2	1.000000e+0	1.000000e+0	1.222277e+1	8.181450e-2	1	8.181450e-2	1.000000e+0	34	8.936961e-2	1.000000e+0	1.000000e+0	1.093394e+1	9.145834e-2	1	825	5.000000e-1	1.212121e-3	unnamed	FA2H
Mouse Phenotype	MP:0001516	abnormal motor coordination/ balance	33	9.929128e-2	1.000000e+0	1.000000e+0	1.007138e+1	9.929128e-2	1	9.929128e-2	1.000000e+0	31	7.897249e-2	1.000000e+0	1.000000e+0	1.240784e+1	8.059420e-2	1	727	5.000000e-1	1.375516e-3	unnamed	FA2H
Mouse Phenotype	MP:0002752	abnormal somatic nervous system morphology	34	1.122886e-1	1.000000e+0	1.000000e+0	8.905622e+0	1.122886e-1	1	1.122886e-1	1.000000e+0	33	8.714662e-2	1.000000e+0	1.000000e+0	1.121953e+1	8.913031e-2	1	804	5.000000e-1	1.243781e-3	unnamed	FA2H
Mouse Phenotype	MP:0003313	abnormal locomotor activation	35	1.143198e-1	1.000000e+0	1.000000e+0	8.747388e+0	1.143198e-1	1	1.143198e-1	1.000000e+0	35	9.675999e-2	1.000000e+0	1.000000e+0	1.007877e+1	9.921845e-2	1	895	5.000000e-1	1.117318e-3	unnamed	FA2H
Mouse Phenotype	MP:0002092	abnormal eye morphology	36	1.428440e-1	1.000000e+0	1.000000e+0	7.000642e+0	1.428440e-1	1	1.428440e-1	1.000000e+0	36	1.188545e-1	1.000000e+0	1.000000e+0	8.155967e+0	1.226096e-1	1	1106	5.000000e-1	9.041591e-4	unnamed	FA2H
Mouse Phenotype	MP:0005391	vision/eye phenotype	37	1.504147e-1	1.000000e+0	1.000000e+0	6.648285e+0	1.504147e-1	1	1.504147e-1	1.000000e+0	37	1.268493e-1	1.000000e+0	1.000000e+0	7.625106e+0	1.311457e-1	1	1183	5.000000e-1	8.453085e-4	unnamed	FA2H
Mouse Phenotype	MP:0001392	abnormal locomotor behavior	38	1.510711e-1	1.000000e+0	1.000000e+0	6.619401e+0	1.510711e-1	1	1.510711e-1	1.000000e+0	38	1.309881e-1	1.000000e+0	1.000000e+0	7.375715e+0	1.355801e-1	1	1223	5.000000e-1	8.176615e-4	unnamed	FA2H
Mouse Phenotype	MP:0003491	abnormal voluntary movement	39	1.639822e-1	1.000000e+0	1.000000e+0	6.098224e+0	1.639822e-1	1	1.639822e-1	1.000000e+0	39	1.399559e-1	1.000000e+0	1.000000e+0	6.885878e+0	1.452248e-1	1	1310	5.000000e-1	7.633588e-4	unnamed	FA2H
Mouse Phenotype	MP:0002882	abnormal neuron morphology	40	1.824896e-1	1.000000e+0	1.000000e+0	5.479764e+0	1.824896e-1	1	1.824896e-1	1.000000e+0	40	1.439609e-1	1.000000e+0	1.000000e+0	6.686805e+0	1.495483e-1	1	1349	5.000000e-1	7.412898e-4	unnamed	FA2H
Mouse Phenotype	MP:0002152	abnormal brain morphology	41	1.867872e-1	1.000000e+0	1.000000e+0	5.353687e+0	1.867872e-1	1	1.867872e-1	1.000000e+0	41	1.513302e-1	1.000000e+0	1.000000e+0	6.347994e+0	1.575301e-1	1	1421	5.000000e-1	7.037298e-4	unnamed	FA2H
Mouse Phenotype	MP:0002066	abnormal motor capabilities/coordination/movement	42	2.177788e-1	1.000000e+0	1.000000e+0	4.591816e+0	2.177788e-1	1	2.177788e-1	1.000000e+0	43	1.858990e-1	1.000000e+0	1.000000e+0	5.116563e+0	1.954437e-1	1	1763	5.000000e-1	5.672150e-4	unnamed	FA2H
Mouse Phenotype	MP:0003633	abnormal nervous system physiology	43	2.225344e-1	1.000000e+0	1.000000e+0	4.493687e+0	2.225344e-1	1	2.225344e-1	1.000000e+0	42	1.816925e-1	1.000000e+0	1.000000e+0	5.241429e+0	1.907877e-1	1	1721	5.000000e-1	5.810575e-4	unnamed	FA2H
Mouse Phenotype	MP:0003632	abnormal nervous system morphology	44	2.827167e-1	1.000000e+0	1.000000e+0	3.537110e+0	2.827167e-1	1	2.827167e-1	1.000000e+0	44	2.350478e-1	1.000000e+0	1.000000e+0	3.987843e+0	2.507622e-1	1	2262	5.000000e-1	4.420866e-4	unnamed	FA2H
Mouse Phenotype	MP:0004924	abnormal behavior	45	2.945352e-1	1.000000e+0	1.000000e+0	3.395180e+0	2.945352e-1	1	2.945352e-1	1.000000e+0	45	2.543172e-1	1.000000e+0	1.000000e+0	3.663891e+0	2.729339e-1	1	2462	5.000000e-1	4.061738e-4	unnamed	FA2H
Mouse Phenotype	MP:0001764	abnormal homeostasis	46	2.990593e-1	1.000000e+0	1.000000e+0	3.343818e+0	2.990593e-1	1	2.990593e-1	1.000000e+0	47	3.044696e-1	1.000000e+0	1.000000e+0	3.011853e+0	3.320215e-1	1	2995	5.000000e-1	3.338898e-4	unnamed	FA2H
Mouse Phenotype	MP:0005376	homeostasis/metabolism phenotype	47	3.389663e-1	1.000000e+0	1.000000e+0	2.950146e+0	3.389663e-1	1	3.389663e-1	1.000000e+0	48	3.467977e-1	1.000000e+0	1.000000e+0	2.607081e+0	3.835708e-1	1	3460	5.000000e-1	2.890173e-4	unnamed	FA2H
Mouse Phenotype	MP:0003631	nervous system phenotype	48	3.410385e-1	1.000000e+0	1.000000e+0	2.932220e+0	3.410385e-1	1	3.410385e-1	1.000000e+0	46	2.844493e-1	1.000000e+0	1.000000e+0	3.244784e+0	3.081869e-1	1	2780	5.000000e-1	3.597122e-4	unnamed	FA2H
Mouse Phenotype	MP:0000001	mammalian phenotype	49	6.422596e-1	1.000000e+0	1.000000e+0	1.557003e+0	6.422596e-1	1	6.422596e-1	1.000000e+0	49	6.601828e-1	1.000000e+0	1.000000e+0	1.198897e+0	8.341001e-1	1	7524	5.000000e-1	1.329080e-4	unnamed	FA2H
Human Phenotype	HP:0006978	Dysmyelinating leukodystrophy	1	1.299516e-4	7.986825e-1	7.986825e-1	7.695171e+3	1.299516e-4	1	1.299516e-4	1.000000e+0	1	2.217111e-4	1.000000e+0	1.000000e+0	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	FA2H
Human Phenotype	HP:0011448	Ankle clonus	2	5.070010e-4	1.000000e+0	1.000000e+0	1.972383e+3	5.070010e-4	1	5.070010e-4	1.000000e+0	2	1.329898e-3	1.000000e+0	1.000000e+0	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	FA2H
Human Phenotype	HP:0001285	Spastic tetraparesis	3	7.837317e-4	1.000000e+0	1.000000e+0	1.275947e+3	7.837317e-4	1	7.837317e-4	1.000000e+0	2	1.329898e-3	1.000000e+0	1.000000e+0	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	FA2H
Human Phenotype	HP:0000012	Urinary urgency	4	9.674684e-4	1.000000e+0	1.000000e+0	1.033625e+3	9.674684e-4	1	9.674684e-4	1.000000e+0	4	1.883760e-3	1.000000e+0	1.000000e+0	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	FA2H
Human Phenotype	HP:0002169	Clonus	5	1.313078e-3	1.000000e+0	1.000000e+0	7.615693e+2	1.313078e-3	1	1.313078e-3	1.000000e+0	7	2.769621e-3	1.000000e+0	1.000000e+0	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	FA2H
Human Phenotype	HP:0000544	External ophthalmoplegia	6	1.883125e-3	1.000000e+0	1.000000e+0	5.310322e+2	1.883125e-3	1	1.883125e-3	1.000000e+0	6	2.548193e-3	1.000000e+0	1.000000e+0	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	FA2H
Human Phenotype	HP:0002518	Abnormality of the periventricular white matter	7	2.024835e-3	1.000000e+0	1.000000e+0	4.938675e+2	2.024835e-3	1	2.024835e-3	1.000000e+0	5	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	FA2H
Human Phenotype	HP:0002415	Leukodystrophy	8	2.491087e-3	1.000000e+0	1.000000e+0	4.014312e+2	2.491087e-3	1	2.491087e-3	1.000000e+0	9	3.987038e-3	1.000000e+0	1.000000e+0	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	FA2H
Human Phenotype	HP:0000020	Urinary incontinence	9	2.878388e-3	1.000000e+0	1.000000e+0	3.474166e+2	2.878388e-3	1	2.878388e-3	1.000000e+0	13	4.761371e-3	1.000000e+0	1.000000e+0	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	FA2H
Human Phenotype	HP:0003028	Abnormality of the ankles	10	3.110689e-3	1.000000e+0	1.000000e+0	3.214722e+2	3.110689e-3	1	3.110689e-3	1.000000e+0	10	4.208307e-3	1.000000e+0	1.000000e+0	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	FA2H
Human Phenotype	HP:0002355	Difficulty walking	11	3.375417e-3	1.000000e+0	1.000000e+0	2.962597e+2	3.375417e-3	1	3.375417e-3	1.000000e+0	8	3.765745e-3	1.000000e+0	1.000000e+0	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	FA2H
Human Phenotype	HP:0002352	Leukoencephalopathy	12	3.484946e-3	1.000000e+0	1.000000e+0	2.869485e+2	3.484946e-3	1	3.484946e-3	1.000000e+0	12	4.429551e-3	1.000000e+0	1.000000e+0	2.255125e+2	4.434344e-3	1	40	5.000000e-1	2.500000e-2	unnamed	FA2H
Human Phenotype	HP:0000602	Ophthalmoplegia	13	4.301437e-3	1.000000e+0	1.000000e+0	2.324805e+2	4.301437e-3	1	4.301437e-3	1.000000e+0	14	5.867038e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	FA2H
Human Phenotype	HP:0002061	Lower limb spasticity	14	4.355900e-3	1.000000e+0	1.000000e+0	2.295737e+2	4.355900e-3	1	4.355900e-3	1.000000e+0	15	5.977571e-3	1.000000e+0	1.000000e+0	1.670463e+2	5.986364e-3	1	54	5.000000e-1	1.851852e-2	unnamed	FA2H
Human Phenotype	HP:0001310	Dysmetria	15	4.406500e-3	1.000000e+0	1.000000e+0	2.269375e+2	4.406500e-3	1	4.406500e-3	1.000000e+0	11	4.318932e-3	1.000000e+0	1.000000e+0	2.312949e+2	4.323485e-3	1	39	5.000000e-1	2.564103e-2	unnamed	FA2H
Human Phenotype	HP:0011400	Abnormal CNS myelination	16	6.500457e-3	1.000000e+0	1.000000e+0	1.538353e+2	6.500457e-3	1	6.500457e-3	1.000000e+0	17	1.061440e-2	1.000000e+0	1.000000e+0	9.396354e+1	1.064243e-2	1	96	5.000000e-1	1.041667e-2	unnamed	FA2H
Human Phenotype	HP:0002079	Hypoplasia of the corpus callosum	17	7.817496e-3	1.000000e+0	1.000000e+0	1.279182e+2	7.817496e-3	1	7.817496e-3	1.000000e+0	16	7.966112e-3	1.000000e+0	1.000000e+0	1.252847e+2	7.981819e-3	1	72	5.000000e-1	1.388889e-2	unnamed	FA2H
Human Phenotype	HP:0001272	Cerebellar atrophy	18	7.839562e-3	1.000000e+0	1.000000e+0	1.275581e+2	7.839562e-3	1	7.839562e-3	1.000000e+0	19	1.193722e-2	1.000000e+0	1.000000e+0	8.352315e+1	1.197273e-2	1	108	5.000000e-1	9.259259e-3	unnamed	FA2H
Human Phenotype	HP:0003487	Babinski sign	19	7.878417e-3	1.000000e+0	1.000000e+0	1.269291e+2	7.878417e-3	1	7.878417e-3	1.000000e+0	18	1.182702e-2	1.000000e+0	1.000000e+0	8.430374e+1	1.186187e-2	1	107	5.000000e-1	9.345794e-3	unnamed	FA2H
Human Phenotype	HP:0004302	Functional motor problems.	20	9.225985e-3	1.000000e+0	1.000000e+0	1.083895e+2	9.225985e-3	1	9.225985e-3	1.000000e+0	20	1.303889e-2	1.000000e+0	1.000000e+0	7.644492e+1	1.308131e-2	1	118	5.000000e-1	8.474576e-3	unnamed	FA2H
Human Phenotype	HP:0001268	Mental deterioration	21	1.001443e-2	1.000000e+0	1.000000e+0	9.985589e+1	1.001443e-2	1	1.001443e-2	1.000000e+0	21	1.314903e-2	1.000000e+0	1.000000e+0	7.580252e+1	1.319217e-2	1	119	5.000000e-1	8.403361e-3	unnamed	FA2H
Human Phenotype	HP:0012447	Abnormal myelination	22	1.038592e-2	1.000000e+0	1.000000e+0	9.628419e+1	1.038592e-2	1	1.038592e-2	1.000000e+0	24	1.568040e-2	1.000000e+0	1.000000e+0	6.352465e+1	1.574192e-2	1	142	5.000000e-1	7.042254e-3	unnamed	FA2H
Human Phenotype	HP:0003676	Progressive disorder	23	1.041484e-2	1.000000e+0	1.000000e+0	9.601683e+1	1.041484e-2	1	1.041484e-2	1.000000e+0	23	1.413995e-2	1.000000e+0	1.000000e+0	7.047266e+1	1.418990e-2	1	128	5.000000e-1	7.812500e-3	unnamed	FA2H
Human Phenotype	HP:0001332	Dystonia	24	1.072440e-2	1.000000e+0	1.000000e+0	9.324529e+1	1.072440e-2	1	1.072440e-2	1.000000e+0	22	1.391979e-2	1.000000e+0	1.000000e+0	7.159127e+1	1.396818e-2	1	126	5.000000e-1	7.936508e-3	unnamed	FA2H
Human Phenotype	HP:0000597	Ophthalmoparesis	25	1.196580e-2	1.000000e+0	1.000000e+0	8.357152e+1	1.196580e-2	1	1.196580e-2	1.000000e+0	25	1.667005e-2	1.000000e+0	1.000000e+0	5.973841e+1	1.673965e-2	1	151	5.000000e-1	6.622517e-3	unnamed	FA2H
Human Phenotype	HP:0002815	Abnormality of the knees	26	1.455165e-2	1.000000e+0	1.000000e+0	6.872073e+1	1.455165e-2	1	1.455165e-2	1.000000e+0	25	1.667005e-2	1.000000e+0	1.000000e+0	5.973841e+1	1.673965e-2	1	151	5.000000e-1	6.622517e-3	unnamed	FA2H
Human Phenotype	HP:0001260	Dysarthria	27	1.657413e-2	1.000000e+0	1.000000e+0	6.033498e+1	1.657413e-2	1	1.657413e-2	1.000000e+0	29	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	FA2H
Human Phenotype	HP:0000009	Functional abnormality of the bladder	28	1.698759e-2	1.000000e+0	1.000000e+0	5.886651e+1	1.698759e-2	1	1.698759e-2	1.000000e+0	27	1.776908e-2	1.000000e+0	1.000000e+0	5.602795e+1	1.784823e-2	1	161	5.000000e-1	6.211180e-3	unnamed	FA2H
Human Phenotype	HP:0000014	Abnormality of the bladder	29	1.747012e-2	1.000000e+0	1.000000e+0	5.724060e+1	1.747012e-2	1	1.747012e-2	1.000000e+0	28	1.853804e-2	1.000000e+0	1.000000e+0	5.369345e+1	1.862424e-2	1	168	5.000000e-1	5.952381e-3	unnamed	FA2H
Human Phenotype	HP:0001257	Spasticity	30	2.102269e-2	1.000000e+0	1.000000e+0	4.756765e+1	2.102269e-2	1	2.102269e-2	1.000000e+0	34	2.828851e-2	1.000000e+0	1.000000e+0	3.509922e+1	2.849066e-2	1	257	5.000000e-1	3.891051e-3	unnamed	FA2H
Human Phenotype	HP:0003679	Pace of progression	31	2.214217e-2	1.000000e+0	1.000000e+0	4.516270e+1	2.214217e-2	1	2.214217e-2	1.000000e+0	32	2.675795e-2	1.000000e+0	1.000000e+0	3.712140e+1	2.693864e-2	1	243	5.000000e-1	4.115226e-3	unnamed	FA2H
Human Phenotype	HP:0007370	Aplasia/Hypoplasia of the corpus callosum	32	2.446174e-2	1.000000e+0	1.000000e+0	4.088017e+1	2.446174e-2	1	2.446174e-2	1.000000e+0	30	2.347414e-2	1.000000e+0	1.000000e+0	4.234977e+1	2.361288e-2	1	213	5.000000e-1	4.694836e-3	unnamed	FA2H
Human Phenotype	HP:0001273	Abnormality of the corpus callosum	33	2.536115e-2	1.000000e+0	1.000000e+0	3.943039e+1	2.536115e-2	1	2.536115e-2	1.000000e+0	31	2.424086e-2	1.000000e+0	1.000000e+0	4.100227e+1	2.438889e-2	1	220	5.000000e-1	4.545455e-3	unnamed	FA2H
Human Phenotype	HP:0001251	Ataxia	34	2.648195e-2	1.000000e+0	1.000000e+0	3.776157e+1	2.648195e-2	1	2.648195e-2	1.000000e+0	36	3.210963e-2	1.000000e+0	1.000000e+0	3.089212e+1	3.237071e-2	1	292	5.000000e-1	3.424658e-3	unnamed	FA2H
Human Phenotype	HP:0002500	Abnormality of the cerebral white matter	35	2.765141e-2	1.000000e+0	1.000000e+0	3.616452e+1	2.765141e-2	1	2.765141e-2	1.000000e+0	33	2.686732e-2	1.000000e+0	1.000000e+0	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	FA2H
Human Phenotype	HP:0001347	Hyperreflexia	36	2.789222e-2	1.000000e+0	1.000000e+0	3.585229e+1	2.789222e-2	1	2.789222e-2	1.000000e+0	39	3.428974e-2	1.000000e+0	1.000000e+0	2.891186e+1	3.458788e-2	1	312	5.000000e-1	3.205128e-3	unnamed	FA2H
Human Phenotype	HP:0000648	Optic atrophy	37	2.952567e-2	1.000000e+0	1.000000e+0	3.386883e+1	2.952567e-2	1	2.952567e-2	1.000000e+0	37	3.374495e-2	1.000000e+0	1.000000e+0	2.938274e+1	3.403359e-2	1	307	5.000000e-1	3.257329e-3	unnamed	FA2H
Human Phenotype	HP:0010993	Abnormality of the cerebral subcortex	38	3.078375e-2	1.000000e+0	1.000000e+0	3.248468e+1	3.078375e-2	1	3.078375e-2	1.000000e+0	35	2.959946e-2	1.000000e+0	1.000000e+0	3.353346e+1	2.982096e-2	1	269	5.000000e-1	3.717472e-3	unnamed	FA2H
Human Phenotype	HP:0000587	Abnormality of the optic nerve	39	3.320424e-2	1.000000e+0	1.000000e+0	3.011663e+1	3.320424e-2	1	3.320424e-2	1.000000e+0	42	3.896867e-2	1.000000e+0	1.000000e+0	2.540986e+1	3.935480e-2	1	355	5.000000e-1	2.816901e-3	unnamed	FA2H
Human Phenotype	HP:0010936	Abnormality of the lower urinary tract	40	3.624123e-2	1.000000e+0	1.000000e+0	2.759288e+1	3.624123e-2	1	3.624123e-2	1.000000e+0	38	3.396288e-2	1.000000e+0	1.000000e+0	2.919256e+1	3.425531e-2	1	309	5.000000e-1	3.236246e-3	unnamed	FA2H
Human Phenotype	HP:0001276	Hypertonia	41	3.644032e-2	1.000000e+0	1.000000e+0	2.744213e+1	3.644032e-2	1	3.644032e-2	1.000000e+0	44	4.135815e-2	1.000000e+0	1.000000e+0	2.392706e+1	4.179369e-2	1	377	5.000000e-1	2.652520e-3	unnamed	FA2H
Human Phenotype	HP:0001288	Gait disturbance	42	3.682158e-2	1.000000e+0	1.000000e+0	2.715798e+1	3.682158e-2	1	3.682158e-2	1.000000e+0	40	3.603207e-2	1.000000e+0	1.000000e+0	2.750152e+1	3.636162e-2	1	328	5.000000e-1	3.048780e-3	unnamed	FA2H
Human Phenotype	HP:0100491	Abnormality of the joints of the lower limbs	43	3.853177e-2	1.000000e+0	1.000000e+0	2.595261e+1	3.853177e-2	1	3.853177e-2	1.000000e+0	40	3.603207e-2	1.000000e+0	1.000000e+0	2.750152e+1	3.636162e-2	1	328	5.000000e-1	3.048780e-3	unnamed	FA2H
Human Phenotype	HP:0011443	Abnormality of coordination	44	4.159660e-2	1.000000e+0	1.000000e+0	2.404043e+1	4.159660e-2	1	4.159660e-2	1.000000e+0	46	4.482844e-2	1.000000e+0	1.000000e+0	2.205501e+1	4.534117e-2	1	409	5.000000e-1	2.444988e-3	unnamed	FA2H
Human Phenotype	HP:0000486	Strabismus	45	4.438473e-2	1.000000e+0	1.000000e+0	2.253027e+1	4.438473e-2	1	4.438473e-2	1.000000e+0	43	4.027239e-2	1.000000e+0	1.000000e+0	2.457902e+1	4.068511e-2	1	367	5.000000e-1	2.724796e-3	unnamed	FA2H
Human Phenotype	HP:0002167	Neurological speech impairment	46	4.456011e-2	1.000000e+0	1.000000e+0	2.244160e+1	4.456011e-2	1	4.456011e-2	1.000000e+0	45	4.276871e-2	1.000000e+0	1.000000e+0	2.312949e+1	4.323485e-2	1	390	5.000000e-1	2.564103e-3	unnamed	FA2H
Human Phenotype	HP:0001317	Abnormality of the cerebellum	47	4.894940e-2	1.000000e+0	1.000000e+0	2.042926e+1	4.894940e-2	1	4.894940e-2	1.000000e+0	48	5.423149e-2	1.000000e+0	1.000000e+0	1.818649e+1	5.498587e-2	1	496	5.000000e-1	2.016129e-3	unnamed	FA2H
Human Phenotype	HP:0000639	Nystagmus	48	5.150322e-2	1.000000e+0	1.000000e+0	1.941626e+1	5.150322e-2	1	5.150322e-2	1.000000e+0	47	5.293728e-2	1.000000e+0	1.000000e+0	1.863740e+1	5.365556e-2	1	484	5.000000e-1	2.066116e-3	unnamed	FA2H
Human Phenotype	HP:0007364	Aplasia/Hypoplasia of the cerebrum	49	5.539730e-2	1.000000e+0	1.000000e+0	1.805142e+1	5.539730e-2	1	5.539730e-2	1.000000e+0	49	5.681724e-2	1.000000e+0	1.000000e+0	1.734712e+1	5.764647e-2	1	520	5.000000e-1	1.923077e-3	unnamed	FA2H
Human Phenotype	HP:0000496	Abnormality of eye movement	50	5.789715e-2	1.000000e+0	1.000000e+0	1.727201e+1	5.789715e-2	1	5.789715e-2	1.000000e+0	50	6.187077e-2	1.000000e+0	1.000000e+0	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	FA2H
Human Phenotype	HP:0007256	Abnormality of pyramidal motor function	51	5.852599e-2	1.000000e+0	1.000000e+0	1.708643e+1	5.852599e-2	1	5.852599e-2	1.000000e+0	51	6.466050e-2	1.000000e+0	1.000000e+0	1.521164e+1	6.573915e-2	1	593	5.000000e-1	1.686341e-3	unnamed	FA2H
Human Phenotype	HP:0002062	Abnormality of the pyramidal tracts	52	5.873395e-2	1.000000e+0	1.000000e+0	1.702593e+1	5.873395e-2	1	5.873395e-2	1.000000e+0	52	6.498213e-2	1.000000e+0	1.000000e+0	1.513507e+1	6.607173e-2	1	596	5.000000e-1	1.677852e-3	unnamed	FA2H
Human Phenotype	HP:0001098	Abnormality of the fundus	53	5.873513e-2	1.000000e+0	1.000000e+0	1.702559e+1	5.873513e-2	1	5.873513e-2	1.000000e+0	52	6.498213e-2	1.000000e+0	1.000000e+0	1.513507e+1	6.607173e-2	1	596	5.000000e-1	1.677852e-3	unnamed	FA2H
Human Phenotype	HP:0004329	Abnormality of the posterior segment of the eye	54	5.909903e-2	1.000000e+0	1.000000e+0	1.692075e+1	5.909903e-2	1	5.909903e-2	1.000000e+0	54	6.541088e-2	1.000000e+0	1.000000e+0	1.503417e+1	6.651516e-2	1	600	5.000000e-1	1.666667e-3	unnamed	FA2H
Human Phenotype	HP:0002977	Aplasia/Hypoplasia involving the central nervous system	55	6.843249e-2	1.000000e+0	1.000000e+0	1.461294e+1	6.843249e-2	1	6.843249e-2	1.000000e+0	56	7.150984e-2	1.000000e+0	1.000000e+0	1.372983e+1	7.283410e-2	1	657	5.000000e-1	1.522070e-3	unnamed	FA2H
Human Phenotype	HP:0100022	Abnormality of movement	56	7.002976e-2	1.000000e+0	1.000000e+0	1.427964e+1	7.002976e-2	1	7.002976e-2	1.000000e+0	57	7.172348e-2	1.000000e+0	1.000000e+0	1.368816e+1	7.305582e-2	1	659	5.000000e-1	1.517451e-3	unnamed	FA2H
Human Phenotype	HP:0001249	Intellectual disability	57	7.044946e-2	1.000000e+0	1.000000e+0	1.419457e+1	7.044946e-2	1	7.044946e-2	1.000000e+0	55	6.551805e-2	1.000000e+0	1.000000e+0	1.500915e+1	6.662602e-2	1	601	5.000000e-1	1.663894e-3	unnamed	FA2H
Human Phenotype	HP:0002060	Abnormality of the cerebrum	58	7.579775e-2	1.000000e+0	1.000000e+0	1.319300e+1	7.579775e-2	1	7.579775e-2	1.000000e+0	60	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	FA2H
Human Phenotype	HP:0100547	Abnormality of the forebrain	59	7.625082e-2	1.000000e+0	1.000000e+0	1.311461e+1	7.625082e-2	1	7.625082e-2	1.000000e+0	61	7.918527e-2	1.000000e+0	1.000000e+0	1.237380e+1	8.081592e-2	1	729	5.000000e-1	1.371742e-3	unnamed	FA2H
Human Phenotype	HP:0001367	Abnormal joint morphology	60	7.644753e-2	1.000000e+0	1.000000e+0	1.308087e+1	7.644753e-2	1	7.644753e-2	1.000000e+0	59	7.545814e-2	1.000000e+0	1.000000e+0	1.299784e+1	7.693587e-2	1	694	5.000000e-1	1.440922e-3	unnamed	FA2H
Human Phenotype	HP:0001250	Seizures	61	7.857598e-2	1.000000e+0	1.000000e+0	1.272654e+1	7.857598e-2	1	7.857598e-2	1.000000e+0	62	8.216155e-2	1.000000e+0	1.000000e+0	1.191612e+1	8.391996e-2	1	757	5.000000e-1	1.321004e-3	unnamed	FA2H
Human Phenotype	HP:0011442	Abnormality of central motor function	62	7.946206e-2	1.000000e+0	1.000000e+0	1.258462e+1	7.946206e-2	1	7.946206e-2	1.000000e+0	63	8.767615e-2	1.000000e+0	1.000000e+0	1.115019e+1	8.968461e-2	1	809	5.000000e-1	1.236094e-3	unnamed	FA2H
Human Phenotype	HP:0002814	Abnormality of the lower limb	63	8.121304e-2	1.000000e+0	1.000000e+0	1.231329e+1	8.121304e-2	1	8.121304e-2	1.000000e+0	58	7.449852e-2	1.000000e+0	1.000000e+0	1.316861e+1	7.593814e-2	1	685	5.000000e-1	1.459854e-3	unnamed	FA2H
Human Phenotype	HP:0000004	Onset and clinical course	64	8.609761e-2	1.000000e+0	1.000000e+0	1.161472e+1	8.609761e-2	1	8.609761e-2	1.000000e+0	68	9.886599e-2	1.000000e+0	1.000000e+0	9.858470e+0	1.014356e-1	1	915	5.000000e-1	1.092896e-3	unnamed	FA2H
Human Phenotype	HP:0000079	Abnormality of the urinary system	65	8.807497e-2	1.000000e+0	1.000000e+0	1.135396e+1	8.807497e-2	1	8.807497e-2	1.000000e+0	64	9.053295e-2	1.000000e+0	1.000000e+0	1.079007e+1	9.267779e-2	1	836	5.000000e-1	1.196172e-3	unnamed	FA2H
Human Phenotype	HP:0012443	Abnormality of the brain	66	9.259756e-2	1.000000e+0	1.000000e+0	1.079942e+1	9.259756e-2	1	9.259756e-2	1.000000e+0	67	9.833972e-2	1.000000e+0	1.000000e+0	9.912637e+0	1.008813e-1	1	910	5.000000e-1	1.098901e-3	unnamed	FA2H
Human Phenotype	HP:0011804	Abnormality of muscle physiology	67	9.636400e-2	1.000000e+0	1.000000e+0	1.037732e+1	9.636400e-2	1	9.636400e-2	1.000000e+0	69	1.050644e-1	1.000000e+0	1.000000e+0	9.261294e+0	1.079763e-1	1	974	5.000000e-1	1.026694e-3	unnamed	FA2H
Human Phenotype	HP:0002813	Abnormality of limb bone morphology	68	1.016983e-1	1.000000e+0	1.000000e+0	9.833005e+0	1.016983e-1	1	1.016983e-1	1.000000e+0	65	9.665462e-2	1.000000e+0	1.000000e+0	1.009004e+1	9.910759e-2	1	894	5.000000e-1	1.118568e-3	unnamed	FA2H
Human Phenotype	HP:0011844	Abnormal appendicular skeleton morphology	69	1.019563e-1	1.000000e+0	1.000000e+0	9.808128e+0	1.019563e-1	1	1.019563e-1	1.000000e+0	66	9.728672e-2	1.000000e+0	1.000000e+0	1.002278e+1	9.977274e-2	1	900	5.000000e-1	1.111111e-3	unnamed	FA2H
Human Phenotype	HP:0012373	Abnormal eye physiology	70	1.069560e-1	1.000000e+0	1.000000e+0	9.349641e+0	1.069560e-1	1	1.069560e-1	1.000000e+0	70	1.137480e-1	1.000000e+0	1.000000e+0	8.534059e+0	1.171775e-1	1	1057	5.000000e-1	9.460738e-4	unnamed	FA2H
Human Phenotype	HP:0012374	Abnormality of the globe	71	1.087826e-1	1.000000e+0	1.000000e+0	9.192650e+0	1.087826e-1	1	1.087826e-1	1.000000e+0	71	1.140610e-1	1.000000e+0	1.000000e+0	8.509906e+0	1.175101e-1	1	1060	5.000000e-1	9.433962e-4	unnamed	FA2H
Human Phenotype	HP:0012372	Abnormal eye morphology	72	1.118366e-1	1.000000e+0	1.000000e+0	8.941615e+0	1.118366e-1	1	1.118366e-1	1.000000e+0	72	1.175012e-1	1.000000e+0	1.000000e+0	8.252973e+0	1.211684e-1	1	1093	5.000000e-1	9.149131e-4	unnamed	FA2H
Human Phenotype	HP:0000119	Abnormality of the genitourinary system	73	1.156102e-1	1.000000e+0	1.000000e+0	8.649757e+0	1.156102e-1	1	1.156102e-1	1.000000e+0	73	1.209346e-1	1.000000e+0	1.000000e+0	8.011101e+0	1.248268e-1	1	1126	5.000000e-1	8.880995e-4	unnamed	FA2H
Human Phenotype	HP:0003011	Abnormality of the musculature	74	1.167900e-1	1.000000e+0	1.000000e+0	8.562375e+0	1.167900e-1	1	1.167900e-1	1.000000e+0	74	1.247763e-1	1.000000e+0	1.000000e+0	7.756234e+0	1.289286e-1	1	1163	5.000000e-1	8.598452e-4	unnamed	FA2H
Human Phenotype	HP:0007319	Morphological abnormality of the central nervous system	75	1.231213e-1	1.000000e+0	1.000000e+0	8.122074e+0	1.231213e-1	1	1.231213e-1	1.000000e+0	75	1.321245e-1	1.000000e+0	1.000000e+0	7.309968e+0	1.367995e-1	1	1234	5.000000e-1	8.103728e-4	unnamed	FA2H
Human Phenotype	HP:0100543	Cognitive impairment	76	1.275944e-1	1.000000e+0	1.000000e+0	7.837337e+0	1.275944e-1	1	1.275944e-1	1.000000e+0	76	1.328473e-1	1.000000e+0	1.000000e+0	7.268735e+0	1.375755e-1	1	1241	5.000000e-1	8.058018e-4	unnamed	FA2H
Human Phenotype	HP:0000007	Autosomal recessive inheritance	77	1.382544e-1	1.000000e+0	1.000000e+0	7.233043e+0	1.382544e-1	1	1.382544e-1	1.000000e+0	81	1.705229e-1	1.000000e+0	1.000000e+0	5.602795e+0	1.784823e-1	1	1610	5.000000e-1	6.211180e-4	unnamed	FA2H
Human Phenotype	HP:0000478	Abnormality of the eye	78	1.387497e-1	1.000000e+0	1.000000e+0	7.207222e+0	1.387497e-1	1	1.387497e-1	1.000000e+0	77	1.483658e-1	1.000000e+0	1.000000e+0	6.480244e+0	1.543152e-1	1	1392	5.000000e-1	7.183908e-4	unnamed	FA2H
Human Phenotype	HP:0011446	Abnormality of higher mental function	79	1.446140e-1	1.000000e+0	1.000000e+0	6.914961e+0	1.446140e-1	1	1.446140e-1	1.000000e+0	78	1.507173e-1	1.000000e+0	1.000000e+0	6.374912e+0	1.568649e-1	1	1415	5.000000e-1	7.067138e-4	unnamed	FA2H
Human Phenotype	HP:0011842	Abnormality of skeletal morphology	80	1.489554e-1	1.000000e+0	1.000000e+0	6.713421e+0	1.489554e-1	1	1.489554e-1	1.000000e+0	79	1.514323e-1	1.000000e+0	1.000000e+0	6.343530e+0	1.576409e-1	1	1422	5.000000e-1	7.032349e-4	unnamed	FA2H
Human Phenotype	HP:0000924	Abnormality of the skeletal system	81	1.521487e-1	1.000000e+0	1.000000e+0	6.572520e+0	1.521487e-1	1	1.521487e-1	1.000000e+0	80	1.555123e-1	1.000000e+0	1.000000e+0	6.169973e+0	1.620753e-1	1	1462	5.000000e-1	6.839945e-4	unnamed	FA2H
Human Phenotype	HP:0002011	Abnormality of the central nervous system	82	1.748665e-1	1.000000e+0	1.000000e+0	5.718647e+0	1.748665e-1	1	1.748665e-1	1.000000e+0	82	1.821938e-1	1.000000e+0	1.000000e+0	5.226246e+0	1.913419e-1	1	1726	5.000000e-1	5.793743e-4	unnamed	FA2H
Human Phenotype	HP:0000707	Abnormality of the nervous system	83	1.846645e-1	1.000000e+0	1.000000e+0	5.415226e+0	1.846645e-1	1	1.846645e-1	1.000000e+0	83	1.902943e-1	1.000000e+0	1.000000e+0	4.991976e+0	2.003215e-1	1	1807	5.000000e-1	5.534034e-4	unnamed	FA2H
Human Phenotype	HP:0000005	Mode of inheritance	84	2.495240e-1	1.000000e+0	1.000000e+0	4.007630e+0	2.495240e-1	1	2.495240e-1	1.000000e+0	84	2.693662e-1	1.000000e+0	1.000000e+0	3.442939e+0	2.904495e-1	1	2620	5.000000e-1	3.816794e-4	unnamed	FA2H
Human Phenotype	HP:0000118	Phenotypic abnormality	85	2.682332e-1	1.000000e+0	1.000000e+0	3.728099e+0	2.682332e-1	1	2.682332e-1	1.000000e+0	85	2.856679e-1	1.000000e+0	1.000000e+0	3.229681e+0	3.096281e-1	1	2793	5.000000e-1	3.580380e-4	unnamed	FA2H
Human Phenotype	HP:0000001	All	86	2.696410e-1	1.000000e+0	1.000000e+0	3.708635e+0	2.696410e-1	1	2.696410e-1	1.000000e+0	86	2.883826e-1	1.000000e+0	1.000000e+0	3.196492e+0	3.128430e-1	1	2822	5.000000e-1	3.543586e-4	unnamed	FA2H
Disease Ontology	DOID:2476	spastic paraplegia	1	9.856441e-4	1.000000e+0	1.000000e+0	1.014565e+3	9.856441e-4	1	9.856441e-4	1.000000e+0	1	1.883760e-3	1.000000e+0	1.000000e+0	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	FA2H
Disease Ontology	DOID:607	paraplegia	2	1.137274e-3	1.000000e+0	1.000000e+0	8.792953e+2	1.137274e-3	1	1.137274e-3	1.000000e+0	2	2.437470e-3	1.000000e+0	1.000000e+0	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	FA2H
Disease Ontology	DOID:543	dystonia	3	4.018201e-3	1.000000e+0	1.000000e+0	2.488676e+2	4.018201e-3	1	4.018201e-3	1.000000e+0	3	4.650770e-3	1.000000e+0	1.000000e+0	2.147738e+2	4.656061e-3	1	42	5.000000e-1	2.380952e-2	unnamed	FA2H
Disease Ontology	DOID:10579	leukodystrophy	4	5.470655e-3	1.000000e+0	1.000000e+0	1.827935e+2	5.470655e-3	1	5.470655e-3	1.000000e+0	4	5.977571e-3	1.000000e+0	1.000000e+0	1.670463e+2	5.986364e-3	1	54	5.000000e-1	1.851852e-2	unnamed	FA2H
Disease Ontology	DOID:1443	cerebral degeneration	5	7.168794e-3	1.000000e+0	1.000000e+0	1.394935e+2	7.168794e-3	1	7.168794e-3	1.000000e+0	5	7.634827e-3	1.000000e+0	1.000000e+0	1.307319e+2	7.649243e-3	1	69	5.000000e-1	1.449275e-2	unnamed	FA2H
Disease Ontology	DOID:936	brain disease	6	1.872681e-1	1.000000e+0	1.000000e+0	5.339937e+0	1.872681e-1	1	1.872681e-1	1.000000e+0	6	1.748588e-1	1.000000e+0	1.000000e+0	5.457048e+0	1.832493e-1	1	1653	5.000000e-1	6.049607e-4	unnamed	FA2H
Disease Ontology	DOID:331	central nervous system disease	7	2.247960e-1	1.000000e+0	1.000000e+0	4.448477e+0	2.247960e-1	1	2.247960e-1	1.000000e+0	7	2.201408e-1	1.000000e+0	1.000000e+0	4.277146e+0	2.338008e-1	1	2109	5.000000e-1	4.741584e-4	unnamed	FA2H
Disease Ontology	DOID:863	nervous system disease	8	2.662634e-1	1.000000e+0	1.000000e+0	3.755680e+0	2.662634e-1	1	2.662634e-1	1.000000e+0	8	2.652858e-1	1.000000e+0	1.000000e+0	3.500388e+0	2.856826e-1	1	2577	5.000000e-1	3.880481e-4	unnamed	FA2H
Disease Ontology	DOID:7	disease of anatomical entity	9	5.144599e-1	1.000000e+0	1.000000e+0	1.943786e+0	5.144599e-1	1	5.144599e-1	1.000000e+0	9	5.469036e-1	1.000000e+0	1.000000e+0	1.529676e+0	6.537332e-1	1	5897	5.000000e-1	1.695778e-4	unnamed	FA2H
Disease Ontology	DOID:4	disease	10	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	10	6.831746e-1	1.000000e+0	1.000000e+0	1.143863e+0	8.742309e-1	1	7886	5.000000e-1	1.268070e-4	unnamed	FA2H
BioCyc Pathway	PWY66-388	fatty acid &alpha;-oxidation III	1	1.631813e-3	5.417619e-1	5.417619e-1	6.128154e+2	1.631813e-3	1	1.631813e-3	1.000000e+0	1	2.769621e-3	9.195142e-1	9.195142e-1	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	FA2H
MSigDB Perturbation	NADERI_BREAST_CANCER_PROGNOSIS_UP	Up-regulated genes in the breast cancer prognostic signature of 70 genes that significantly correlated with survival.	1	4.152966e-3	1.000000e+0	1.000000e+0	2.407917e+2	4.152966e-3	1	4.152966e-3	1.000000e+0	1	5.314281e-3	1.000000e+0	1.000000e+0	1.879271e+2	5.321213e-3	1	48	5.000000e-1	2.083333e-2	unnamed	FA2H
MSigDB Perturbation	OUILLETTE_CLL_13Q14_DELETION_UP	Genes up-regulated in chronic lymphocytic leukemia (CLL) samples bearing deletions in the 13q14 region.	2	6.124707e-3	1.000000e+0	1.000000e+0	1.632731e+2	6.124707e-3	1	6.124707e-3	1.000000e+0	6	9.511379e-3	1.000000e+0	1.000000e+0	1.048895e+2	9.533840e-3	1	86	5.000000e-1	1.162791e-2	unnamed	WDR59
MSigDB Perturbation	GRABARCZYK_BCL11B_TARGETS_DN	Genes down-regulated in Jurkat cells (transformed T lymphocytes) after knockdown of BCL11B [GeneID=64919] by RNAi.	3	6.309917e-3	1.000000e+0	1.000000e+0	1.584807e+2	6.309917e-3	1	6.309917e-3	1.000000e+0	2	5.977571e-3	1.000000e+0	1.000000e+0	1.670463e+2	5.986364e-3	1	54	5.000000e-1	1.851852e-2	unnamed	FA2H
MSigDB Perturbation	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP	Genes up-regulated in HEK-293 cells (fibroblast) upon knockdown of both CTBP1 and SATB1 [GeneID=1487, 6304] by RNAi.	4	7.024133e-3	1.000000e+0	1.000000e+0	1.423663e+2	7.024133e-3	1	7.024133e-3	1.000000e+0	5	9.069997e-3	1.000000e+0	1.000000e+0	1.100061e+2	9.090405e-3	1	82	5.000000e-1	1.219512e-2	unnamed	WDR59
MSigDB Perturbation	LEIN_OLIGODENDROCYTE_MARKERS	Genes enriched in oligodendrocytes in the adult mouse brain identified through correlation-based searches seeded with the oligodendrocyte cell-type specific gene expression patterns.	5	7.406308e-3	1.000000e+0	1.000000e+0	1.350200e+2	7.406308e-3	1	7.406308e-3	1.000000e+0	4	8.186938e-3	1.000000e+0	1.000000e+0	1.218986e+2	8.203536e-3	1	74	5.000000e-1	1.351351e-2	unnamed	FA2H
MSigDB Perturbation	DOANE_BREAST_CANCER_CLASSES_UP	Genes up-regulated in ER(-) / PR(-) breast tumors (do not express ESR1 and PGR [GeneID=2099;5241]) with molecular similarity to ER(+) (class A) relative to the rest of the ER(-) / PR(-) samples (class B).	6	8.210396e-3	1.000000e+0	1.000000e+0	1.217968e+2	8.210396e-3	1	8.210396e-3	1.000000e+0	3	7.303486e-3	1.000000e+0	1.000000e+0	1.366742e+2	7.316668e-3	1	66	5.000000e-1	1.515152e-2	unnamed	FA2H
MSigDB Perturbation	SMID_BREAST_CANCER_ERBB2_UP	Genes up-regulated in the erbb2 subype of breast cancer samples, characterized by higher expression of ERBB2 [GeneID=2064].	7	1.010671e-2	1.000000e+0	1.000000e+0	9.894420e+1	1.010671e-2	1	1.010671e-2	1.000000e+0	8	1.469025e-2	1.000000e+0	1.000000e+0	6.782331e+1	1.474419e-2	1	133	5.000000e-1	7.518797e-3	unnamed	FA2H
MSigDB Perturbation	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	Genes up-regulated in mucinous ovarian carcinoma tumors of low malignant potential (LMP) compared to normal ovarian surface epithelium tissue.	8	1.814520e-2	1.000000e+0	1.000000e+0	5.511099e+1	1.814520e-2	1	1.814520e-2	1.000000e+0	14	2.785133e-2	1.000000e+0	1.000000e+0	3.565415e+1	2.804723e-2	1	253	5.000000e-1	3.952569e-3	unnamed	FA2H
MSigDB Perturbation	RODWELL_AGING_KIDNEY_NO_BLOOD_DN	Genes whose expression decreases with age in normal kidney, excluding those with higher expression in blood.	9	1.978642e-2	1.000000e+0	1.000000e+0	5.053971e+1	1.978642e-2	1	1.978642e-2	1.000000e+0	9	1.546041e-2	1.000000e+0	1.000000e+0	6.443214e+1	1.552020e-2	1	140	5.000000e-1	7.142857e-3	unnamed	FA2H
MSigDB Perturbation	PROVENZANI_METASTASIS_UP	Genes up-regulated in polysomal and total RNA samples from SW480 cells (primary colorectal carcinoma, CRC) compared to the SW620 cells (lymph node metastasis from the same individual).	10	2.168008e-2	1.000000e+0	1.000000e+0	4.612529e+1	2.168008e-2	1	2.168008e-2	1.000000e+0	11	2.204943e-2	1.000000e+0	1.000000e+0	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	WDR59
MSigDB Perturbation	OKUMURA_INFLAMMATORY_RESPONSE_LPS	Genes up-regulated in mast cells (MC) after stimulation with a bacterial lipopolysaccharide (LPS).	11	2.328889e-2	1.000000e+0	1.000000e+0	4.293893e+1	2.328889e-2	1	2.328889e-2	1.000000e+0	10	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	FA2H
MSigDB Perturbation	HOELZEL_NF1_TARGETS_DN	Genes down-regulated in SH-SY5Y cells (neuroblastoma) after knockdown of NF1 [GeneID=4763] by RNAi.	12	2.407464e-2	1.000000e+0	1.000000e+0	4.153748e+1	2.407464e-2	1	2.407464e-2	1.000000e+0	7	1.116569e-2	1.000000e+0	1.000000e+0	8.931188e+1	1.119672e-2	1	101	5.000000e-1	9.900990e-3	unnamed	WDR59
MSigDB Perturbation	HUTTMANN_B_CLL_POOR_SURVIVAL_UP	Up-regulated genes in B-CLL (B-cell chronic leukemia) patients expressing high levels of ZAP70 and CD38 [GeneID=7535;952], which are associated with poor survival.	13	2.578171e-2	1.000000e+0	1.000000e+0	3.878719e+1	2.578171e-2	1	2.578171e-2	1.000000e+0	15	2.905334e-2	1.000000e+0	1.000000e+0	3.416856e+1	2.926667e-2	1	264	5.000000e-1	3.787879e-3	unnamed	FA2H
MSigDB Perturbation	MULLIGHAN_MLL_SIGNATURE_1_DN	The 'MLL signature 1': genes down-regulated in pediatric AML (acute myeloid leukemia) with rearranged MLL [GeneID=4297] compared to all AML cases with the intact gene.	14	2.877798e-2	1.000000e+0	1.000000e+0	3.474880e+1	2.877798e-2	1	2.877798e-2	1.000000e+0	13	2.599222e-2	1.000000e+0	1.000000e+0	3.822246e+1	2.616263e-2	1	236	5.000000e-1	4.237288e-3	unnamed	WDR59
MSigDB Perturbation	STEIN_ESRRA_TARGETS_UP	Genes up-regulated by ESRRA [GeneID=2101] only.	15	3.184050e-2	1.000000e+0	1.000000e+0	3.140654e+1	3.184050e-2	1	3.184050e-2	1.000000e+0	18	4.157523e-2	1.000000e+0	1.000000e+0	2.380079e+1	4.201541e-2	1	379	5.000000e-1	2.638522e-3	unnamed	FA2H
MSigDB Perturbation	VERHAAK_GLIOBLASTOMA_CLASSICAL	Genes correlated with classical type of glioblastoma multiforme tumors.	16	3.391831e-2	1.000000e+0	1.000000e+0	2.948260e+1	3.391831e-2	1	3.391831e-2	1.000000e+0	12	2.237830e-2	1.000000e+0	1.000000e+0	4.443596e+1	2.250430e-2	1	203	5.000000e-1	4.926108e-3	unnamed	FA2H
MSigDB Perturbation	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP	Genes up-regulated in luminal-like breast cancer cell lines compared to the mesenchymal-like ones.	17	3.402913e-2	1.000000e+0	1.000000e+0	2.938658e+1	3.402913e-2	1	3.402913e-2	1.000000e+0	23	4.591162e-2	1.000000e+0	1.000000e+0	2.152864e+1	4.644975e-2	1	419	5.000000e-1	2.386635e-3	unnamed	FA2H
MSigDB Perturbation	MULLIGHAN_MLL_SIGNATURE_2_DN	The 'MLL signature 2': genes down-regulated in pediatric AML (acute myeloid leukemia) with rearranged MLL [GeneID=4297] compared to the AML cases with intact MLL and NPM1 [GeneID=4869].	18	3.439238e-2	1.000000e+0	1.000000e+0	2.907621e+1	3.439238e-2	1	3.439238e-2	1.000000e+0	16	3.036376e-2	1.000000e+0	1.000000e+0	3.268297e+1	3.059697e-2	1	276	5.000000e-1	3.623188e-3	unnamed	WDR59
MSigDB Perturbation	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP	Up-regulated genes distinguishing in multiple myeloma (MM) samples with higher expression of TACI [GeneID=23495].	19	3.520499e-2	1.000000e+0	1.000000e+0	2.840506e+1	3.520499e-2	1	3.520499e-2	1.000000e+0	21	4.352782e-2	1.000000e+0	1.000000e+0	2.272166e+1	4.401086e-2	1	397	5.000000e-1	2.518892e-3	unnamed	FA2H
MSigDB Perturbation	ODONNELL_TFRC_TARGETS_UP	Genes up-regulated in P493-6 cells (B lymphocyte, Burkitt's lymphoma model) upon knockdown of TFRC [GeneID=7037] by RNAi.	20	4.149779e-2	1.000000e+0	1.000000e+0	2.409767e+1	4.149779e-2	1	4.149779e-2	1.000000e+0	19	4.190080e-2	1.000000e+0	1.000000e+0	2.361387e+1	4.234799e-2	1	382	5.000000e-1	2.617801e-3	unnamed	WDR59
MSigDB Perturbation	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	Genes up-regulated in ME-A cells (breast cancer, sensitive to apoptotic stimuli) exposed to doxorubicin [PubChem=31703] in the presence of medium concentrate (MC) from ME-C cells (breast cancer, resistant to apoptotic stimuli).	21	4.262412e-2	1.000000e+0	1.000000e+0	2.346089e+1	4.262412e-2	1	4.262412e-2	1.000000e+0	30	6.519651e-2	1.000000e+0	1.000000e+0	1.508445e+1	6.629344e-2	1	598	5.000000e-1	1.672241e-3	unnamed	FA2H
MSigDB Perturbation	RATTENBACHER_BOUND_BY_CELF1	Transcripts bound by CELF1 [GeneID=10658] in HeLa cells (cervical carcinoma).	22	4.334171e-2	1.000000e+0	1.000000e+0	2.307247e+1	4.334171e-2	1	4.334171e-2	1.000000e+0	20	4.341939e-2	1.000000e+0	1.000000e+0	2.277904e+1	4.390001e-2	1	396	5.000000e-1	2.525253e-3	unnamed	WDR59
MSigDB Perturbation	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN	Cluster 2: genes down-regulated in lung tissue samples from mice with oncogenic form of KRAS [GeneID=3845] and inactivated PTEN [GeneID=5728].	23	4.514819e-2	1.000000e+0	1.000000e+0	2.214928e+1	4.514819e-2	1	4.514819e-2	1.000000e+0	17	3.624975e-2	1.000000e+0	1.000000e+0	2.733485e+1	3.658334e-2	1	330	5.000000e-1	3.030303e-3	unnamed	FA2H
MSigDB Perturbation	STEIN_ESRRA_TARGETS	Genes regulated by ESRRA [GeneID=2101] in MCF-7 cells (breast cancer).	24	4.591289e-2	1.000000e+0	1.000000e+0	2.178037e+1	4.591289e-2	1	4.591289e-2	1.000000e+0	25	5.724786e-2	1.000000e+0	1.000000e+0	1.721469e+1	5.808991e-2	1	524	5.000000e-1	1.908397e-3	unnamed	FA2H
MSigDB Perturbation	FOSTER_TOLERANT_MACROPHAGE_DN	Class NT (non-tolerizeable) genes: induced during the first LPS stimulation and induced at equal or greater degree in tolerant macrophages.	25	5.132241e-2	1.000000e+0	1.000000e+0	1.948467e+1	5.132241e-2	1	5.132241e-2	1.000000e+0	22	4.439500e-2	1.000000e+0	1.000000e+0	2.227284e+1	4.489773e-2	1	405	5.000000e-1	2.469136e-3	unnamed	WDR59
MSigDB Perturbation	MEISSNER_NPC_HCP_WITH_H3K4ME2	Genes with high-CpG-density promoters (HCP) bearing histone H3 dimethylation mark at K4 (H3K4me2) in neural precursor cells (NPC).	26	5.352102e-2	1.000000e+0	1.000000e+0	1.868425e+1	5.352102e-2	1	5.352102e-2	1.000000e+0	24	5.023817e-2	1.000000e+0	1.000000e+0	1.965251e+1	5.088410e-2	1	459	5.000000e-1	2.178649e-3	unnamed	FA2H
MSigDB Perturbation	MARTINEZ_RB1_TARGETS_DN	Genes down-regulated in mice with skin specific knockout of RB1 [GeneID=5925] by Cre-lox.	27	5.382228e-2	1.000000e+0	1.000000e+0	1.857967e+1	5.382228e-2	1	5.382228e-2	1.000000e+0	25	5.724786e-2	1.000000e+0	1.000000e+0	1.721469e+1	5.808991e-2	1	524	5.000000e-1	1.908397e-3	unnamed	FA2H
MSigDB Perturbation	MARTINEZ_RB1_AND_TP53_TARGETS_DN	Genes down-regulated in mice with skin specific double knockout of both RB1 and TP53 [GeneID=5925;7157] by Cre-lox.	28	5.800771e-2	1.000000e+0	1.000000e+0	1.723909e+1	5.800771e-2	1	5.800771e-2	1.000000e+0	27	6.219287e-2	1.000000e+0	1.000000e+0	1.582544e+1	6.318940e-2	1	570	5.000000e-1	1.754386e-3	unnamed	FA2H
MSigDB Perturbation	MARTINEZ_TP53_TARGETS_DN	Genes down-regulated in mice with skin specific knockout of TP53 [GeneID=7157].	29	5.892566e-2	1.000000e+0	1.000000e+0	1.697053e+1	5.892566e-2	1	5.892566e-2	1.000000e+0	28	6.262226e-2	1.000000e+0	1.000000e+0	1.571516e+1	6.363284e-2	1	574	5.000000e-1	1.742160e-3	unnamed	FA2H
MSigDB Perturbation	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN	Down-regulated genes in peripheral zone of human pancreatic cancer growing in the pancreas of nude mice compared to that of the tumor from the central zone.	30	6.253641e-2	1.000000e+0	1.000000e+0	1.599068e+1	6.253641e-2	1	6.253641e-2	1.000000e+0	29	6.508932e-2	1.000000e+0	1.000000e+0	1.510972e+1	6.618258e-2	1	597	5.000000e-1	1.675042e-3	unnamed	FA2H
MSigDB Perturbation	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	Genes up-regulated in ME-A cells (breast cancer) undergoing apoptosis in response to doxorubicin [PubChem=31703].	31	7.551862e-2	1.000000e+0	1.000000e+0	1.324177e+1	7.551862e-2	1	7.551862e-2	1.000000e+0	35	1.189586e-1	1.000000e+0	1.000000e+0	8.148600e+0	1.227205e-1	1	1107	5.000000e-1	9.033424e-4	unnamed	FA2H
MSigDB Perturbation	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	Genes up-regulated in T24 (bladder cancer) cells in response to the photodynamic therapy (PDT) stress.	32	7.787022e-2	1.000000e+0	1.000000e+0	1.284188e+1	7.787022e-2	1	7.787022e-2	1.000000e+0	31	8.555712e-2	1.000000e+0	1.000000e+0	1.143283e+1	8.746744e-2	1	789	5.000000e-1	1.267427e-3	unnamed	FA2H
MSigDB Perturbation	MARSON_BOUND_BY_FOXP3_STIMULATED	Genes with promoters bound by FOXP3 [GeneID=50943] in hybridoma cells stimulated by PMA [PubChem=4792] and ionomycin [PubChem=3733].	33	7.982095e-2	1.000000e+0	1.000000e+0	1.252804e+1	7.982095e-2	1	7.982095e-2	1.000000e+0	32	1.065321e-1	1.000000e+0	1.000000e+0	9.130061e+0	1.095283e-1	1	988	5.000000e-1	1.012146e-3	unnamed	WDR59
MSigDB Perturbation	PEREZ_TP53_TARGETS	Genes up-regulated in the HMEC cells (primary mammary epithelium) upon expression of TP53 [GeneID=7157] off adenoviral vector.	34	1.077316e-1	1.000000e+0	1.000000e+0	9.282326e+0	1.077316e-1	1	1.077316e-1	1.000000e+0	34	1.145827e-1	1.000000e+0	1.000000e+0	8.469953e+0	1.180644e-1	1	1065	5.000000e-1	9.389671e-4	unnamed	FA2H
MSigDB Perturbation	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	Genes down-regulated during differentiation of Oli-Neu cells (oligodendroglial precursor) in response to PD174265 [PubChemID=4709].	35	1.243698e-1	1.000000e+0	1.000000e+0	8.040539e+0	1.243698e-1	1	1.243698e-1	1.000000e+0	33	1.115549e-1	1.000000e+0	1.000000e+0	8.707046e+0	1.148495e-1	1	1036	5.000000e-1	9.652510e-4	unnamed	FA2H
MSigDB Perturbation	DODD_NASOPHARYNGEAL_CARCINOMA_UP	Genes up-regulated in nasopharyngeal carcinoma (NPC) compared to the normal tissue.	36	1.332338e-1	1.000000e+0	1.000000e+0	7.505605e+0	1.332338e-1	1	1.332338e-1	1.000000e+0	36	1.575486e-1	1.000000e+0	1.000000e+0	6.086707e+0	1.642924e-1	1	1482	5.000000e-1	6.747638e-4	unnamed	FA2H
MSigDB Perturbation	BLALOCK_ALZHEIMERS_DISEASE_UP	Genes up-regulated in brain from patients with Alzheimer's disease.	37	1.561268e-1	1.000000e+0	1.000000e+0	6.405052e+0	1.561268e-1	1	1.561268e-1	1.000000e+0	37	1.768717e-1	1.000000e+0	1.000000e+0	5.391811e+0	1.854664e-1	1	1673	5.000000e-1	5.977286e-4	unnamed	FA2H
MSigDB Predicted Promoter Motifs	V$NFY_01	Motif NNNRRCCAATSRGNNN (no known TF)	1	2.703791e-2	1.000000e+0	1.000000e+0	3.698511e+1	2.703791e-2	1	2.703791e-2	1.000000e+0	2	2.708603e-2	1.000000e+0	1.000000e+0	3.666870e+1	2.727122e-2	1	246	5.000000e-1	4.065041e-3	unnamed	FA2H
MSigDB Predicted Promoter Motifs	V$AREB6_03	Motif VNRCACCTGKNC matches TCF8: transcription factor 8 (represses interleukin 2 expression)	2	3.154534e-2	1.000000e+0	1.000000e+0	3.170040e+1	3.154534e-2	1	3.154534e-2	1.000000e+0	3	2.719538e-2	1.000000e+0	1.000000e+0	3.652024e+1	2.738207e-2	1	247	5.000000e-1	4.048583e-3	unnamed	FA2H
MSigDB Predicted Promoter Motifs	V$AR_Q6	Motif WGAGCANRN matches AR: androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease)	3	3.163805e-2	1.000000e+0	1.000000e+0	3.160751e+1	3.163805e-2	1	3.163805e-2	1.000000e+0	1	2.632043e-2	1.000000e+0	1.000000e+0	3.774268e+1	2.649521e-2	1	239	5.000000e-1	4.184100e-3	unnamed	FA2H
MSigDB Predicted Promoter Motifs	GCANCTGNY_V$MYOD_Q6	Motif GCANCTGNY matches MYOD1: myogenic differentiation 1	4	1.148568e-1	1.000000e+0	1.000000e+0	8.706491e+0	1.148568e-1	1	1.148568e-1	1.000000e+0	4	9.560063e-2	1.000000e+0	1.000000e+0	1.020419e+1	9.799900e-2	1	884	5.000000e-1	1.131222e-3	unnamed	FA2H
MSigDB Predicted Promoter Motifs	CAGGTG_V$E12_Q6	Motif CAGGTG matches TCF3: transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)	5	2.657598e-1	1.000000e+0	1.000000e+0	3.762796e+0	2.657598e-1	1	2.657598e-1	1.000000e+0	5	2.455801e-1	1.000000e+0	1.000000e+0	3.804513e+0	2.628457e-1	1	2371	5.000000e-1	4.217630e-4	unnamed	FA2H
MSigDB miRNA Motifs	TACTTGA,MIR-26A,MIR-26B	Targets of MicroRNA TACTTGA,MIR-26A,MIR-26B	1	4.708394e-2	1.000000e+0	1.000000e+0	2.123867e+1	4.708394e-2	1	4.708394e-2	1.000000e+0	1	3.178240e-2	1.000000e+0	1.000000e+0	3.121280e+1	3.203814e-2	1	289	5.000000e-1	3.460208e-3	unnamed	FA2H
MSigDB miRNA Motifs	TGCCTTA,MIR-124A	Targets of MicroRNA TGCCTTA,MIR-124A	2	7.778816e-2	1.000000e+0	1.000000e+0	1.285543e+1	7.778816e-2	1	7.778816e-2	1.000000e+0	2	5.800120e-2	1.000000e+0	1.000000e+0	1.698776e+1	5.886592e-2	1	531	5.000000e-1	1.883239e-3	unnamed	FA2H
InterPro	IPR014430	Inositolphosphorylceramide-B hydroxylase	1	9.723874e-5	9.161834e-1	9.161834e-1	1.028397e+4	9.723874e-5	1	9.723874e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	FA2H
InterPro	IPR018506	Cytochrome b5, heme-binding site	2	3.330240e-4	1.000000e+0	1.000000e+0	3.002786e+3	3.330240e-4	1	3.330240e-4	1.000000e+0	2	5.542315e-4	1.000000e+0	1.000000e+0	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	FA2H
InterPro	IPR006575	RWD domain	3	6.817515e-4	1.000000e+0	1.000000e+0	1.466810e+3	6.817515e-4	1	6.817515e-4	1.000000e+0	4	1.108309e-3	1.000000e+0	1.000000e+0	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	WDR59
InterPro	IPR006694	Fatty acid hydroxylase	4	6.851443e-4	1.000000e+0	1.000000e+0	1.459547e+3	6.851443e-4	1	6.851443e-4	1.000000e+0	3	6.650594e-4	1.000000e+0	1.000000e+0	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	FA2H
InterPro	IPR001199	Cytochrome b5-like heme/steroid binding domain	5	9.914791e-4	1.000000e+0	1.000000e+0	1.008594e+3	9.914791e-4	1	9.914791e-4	1.000000e+0	5	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	FA2H
InterPro	IPR016135	Ubiquitin-conjugating enzyme/RWD-like	6	4.550021e-3	1.000000e+0	1.000000e+0	2.197792e+2	4.550021e-3	1	4.550021e-3	1.000000e+0	6	6.198618e-3	1.000000e+0	1.000000e+0	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	WDR59
InterPro	IPR019775	WD40 repeat, conserved site	7	1.473828e-2	1.000000e+0	1.000000e+0	6.785052e+1	1.473828e-2	1	1.473828e-2	1.000000e+0	7	1.612031e-2	1.000000e+0	1.000000e+0	6.178425e+1	1.618536e-2	1	146	5.000000e-1	6.849315e-3	unnamed	WDR59
InterPro	IPR001680	WD40 repeat	8	2.194468e-2	1.000000e+0	1.000000e+0	4.556913e+1	2.194468e-2	1	2.194468e-2	1.000000e+0	8	2.566396e-2	1.000000e+0	1.000000e+0	3.871459e+1	2.583005e-2	1	233	5.000000e-1	4.291845e-3	unnamed	WDR59
InterPro	IPR017986	WD40-repeat-containing domain	9	2.441726e-2	1.000000e+0	1.000000e+0	4.095463e+1	2.441726e-2	1	2.441726e-2	1.000000e+0	9	2.883484e-2	1.000000e+0	1.000000e+0	3.442939e+1	2.904495e-2	1	262	5.000000e-1	3.816794e-3	unnamed	WDR59
InterPro	IPR015943	WD40/YVTN repeat-like-containing domain	10	3.149630e-2	1.000000e+0	1.000000e+0	3.174976e+1	3.149630e-2	1	3.149630e-2	1.000000e+0	10	3.298197e-2	1.000000e+0	1.000000e+0	3.006833e+1	3.325758e-2	1	300	5.000000e-1	3.333333e-3	unnamed	WDR59
TreeFam	TF314695	WDR59	1	7.486119e-5	6.083220e-1	6.083220e-1	1.335806e+4	7.486119e-5	1	7.486119e-5	1.000000e+0	1	1.108586e-4	9.008370e-1	9.008370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	WDR59
TreeFam	TF314955	FA2H	2	9.723874e-5	7.901620e-1	3.950810e-1	1.028397e+4	9.723874e-5	1	9.723874e-5	1.000000e+0	1	1.108586e-4	9.008370e-1	9.008370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	FA2H
HGNC Gene Families	FATHD	FATHD	1	6.851443e-4	3.274990e-1	3.274990e-1	1.459547e+3	6.851443e-4	1	6.851443e-4	1.000000e+0	1	6.650594e-4	3.178984e-1	3.178984e-1	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	FA2H
HGNC Gene Families	WDR	WDR	2	1.502034e-2	1.000000e+0	1.000000e+0	6.657639e+1	1.502034e-2	1	1.502034e-2	1.000000e+0	2	1.765921e-2	1.000000e+0	1.000000e+0	5.637812e+1	1.773738e-2	1	160	5.000000e-1	6.250000e-3	unnamed	WDR59
Ensembl Genes	7556	WDR59	1	7.486119e-5	1.000000e+0	1.000000e+0	1.335806e+4	7.486119e-5	1	7.486119e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	WDR59
Ensembl Genes	7555	FA2H	2	9.723874e-5	1.000000e+0	8.771421e-1	1.028397e+4	9.723874e-5	1	9.723874e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	FA2H
MSigDB Oncogenic Signatures	CAHOY_OLIGODENDROCUTIC	Genes up-regulated in oligodendrocytes.	1	1.422016e-2	1.000000e+0	1.000000e+0	7.032270e+1	1.422016e-2	1	1.422016e-2	1.000000e+0	1	1.050413e-2	1.000000e+0	1.000000e+0	9.495263e+1	1.053157e-2	1	95	5.000000e-1	1.052632e-2	unnamed	FA2H
MSigDB Oncogenic Signatures	IL21_UP.V1_UP	Genes up-regulated in Sez-4 cells (T lymphocyte) that were first starved of IL2 [Gene ID=3558] and then stimulated with IL21 [Gene ID=59067].	2	1.542574e-2	1.000000e+0	1.000000e+0	6.482672e+1	1.542574e-2	1	1.542574e-2	1.000000e+0	2	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	FA2H
MSigDB Oncogenic Signatures	LTE2_UP.V1_UP	Genes up-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) and long-term adapted for estrogen-independent growth.	3	2.269124e-2	1.000000e+0	1.000000e+0	4.406987e+1	2.269124e-2	1	2.269124e-2	1.000000e+0	3	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	FA2H
MSigDB Immunologic Signatures	GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_UP	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute E. coli infection.	1	1.021857e-2	1.000000e+0	1.000000e+0	9.786105e+1	1.021857e-2	1	1.021857e-2	1.000000e+0	4	1.809867e-2	1.000000e+0	1.000000e+0	5.500305e+1	1.818081e-2	1	164	5.000000e-1	6.097561e-3	unnamed	WDR59
MSigDB Immunologic Signatures	GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP	Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 3 h versus PMN treated with F. tularensis vaccine at 3 h.	2	1.251443e-2	1.000000e+0	1.000000e+0	7.990773e+1	1.251443e-2	1	1.251443e-2	1.000000e+0	5	1.897731e-2	1.000000e+0	1.000000e+0	5.244477e+1	1.906768e-2	1	172	5.000000e-1	5.813953e-3	unnamed	FA2H
MSigDB Immunologic Signatures	GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 2 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 2 h.	3	1.314772e-2	1.000000e+0	1.000000e+0	7.605881e+1	1.314772e-2	1	1.314772e-2	1.000000e+0	2	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	WDR59
MSigDB Immunologic Signatures	GSE6269_HEALTHY_VS_STREP_PNEUMO_INF_PBMC_UP	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute S. pneumoniae infection.	4	1.423355e-2	1.000000e+0	1.000000e+0	7.025652e+1	1.423355e-2	1	1.423355e-2	1.000000e+0	6	1.963603e-2	1.000000e+0	1.000000e+0	5.067697e+1	1.973283e-2	1	178	5.000000e-1	5.617978e-3	unnamed	WDR59
MSigDB Immunologic Signatures	GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP	Genes up-regulated in comparison of CD4 [GeneID=920] effector memory T cells versus CD4 [GeneID=920] CXCR5+ [GeneID=643] T cells.	5	1.426556e-2	1.000000e+0	1.000000e+0	7.009892e+1	1.426556e-2	1	1.426556e-2	1.000000e+0	6	1.963603e-2	1.000000e+0	1.000000e+0	5.067697e+1	1.973283e-2	1	178	5.000000e-1	5.617978e-3	unnamed	FA2H
MSigDB Immunologic Signatures	GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with R848 at 2 h versus DCs stimulated with LPS (TLR4 agonist) at 8 h.	6	1.465645e-2	1.000000e+0	1.000000e+0	6.822937e+1	1.465645e-2	1	1.465645e-2	1.000000e+0	19	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	FA2H
MSigDB Immunologic Signatures	GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_UP	Genes up-regulated in comparison of naive CD8 T cells versus effector CD8 T cells KLRG1 Int [GeneID=10219].	7	1.475455e-2	1.000000e+0	1.000000e+0	6.777572e+1	1.475455e-2	1	1.475455e-2	1.000000e+0	12	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	WDR59
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 14 h.	8	1.480092e-2	1.000000e+0	1.000000e+0	6.756336e+1	1.480092e-2	1	1.480092e-2	1.000000e+0	19	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	FA2H
MSigDB Immunologic Signatures	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_DN	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 0.5 h versus the untreated cells at 0.5 h.	9	1.490294e-2	1.000000e+0	1.000000e+0	6.710084e+1	1.490294e-2	1	1.490294e-2	1.000000e+0	1	1.568040e-2	1.000000e+0	1.000000e+0	6.352465e+1	1.574192e-2	1	142	5.000000e-1	7.042254e-3	unnamed	FA2H
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 1 h versus those stimulated with Gardiquimod (TLR7 agonist) at 1 h.	10	1.505341e-2	1.000000e+0	1.000000e+0	6.643014e+1	1.505341e-2	1	1.505341e-2	1.000000e+0	28	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	FA2H
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 18 h.	11	1.509093e-2	1.000000e+0	1.000000e+0	6.626495e+1	1.509093e-2	1	1.509093e-2	1.000000e+0	27	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	FA2H
MSigDB Immunologic Signatures	GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 1 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 1 h.	12	1.523210e-2	1.000000e+0	1.000000e+0	6.565083e+1	1.523210e-2	1	1.523210e-2	1.000000e+0	23	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	FA2H
MSigDB Immunologic Signatures	GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_UP	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 3 days after stimulation with YF17D vaccine versus PBMC 7 days after the stimulation.	13	1.564725e-2	1.000000e+0	1.000000e+0	6.390901e+1	1.564725e-2	1	1.564725e-2	1.000000e+0	3	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	FA2H
MSigDB Immunologic Signatures	GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_DN	Genes down-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus CD4 [GeneID=920] Int CD8 thymocytes.	14	1.568037e-2	1.000000e+0	1.000000e+0	6.377401e+1	1.568037e-2	1	1.568037e-2	1.000000e+0	25	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	FA2H
MSigDB Immunologic Signatures	GSE2706_UNSTIM_VS_8H_LPS_DC_UP	Genes up-regulated in comparison of unstimulated dendritic cells (DC) at 0 h versus DCs stimulated with LPS (TLR4 agonist) for 8 h.	15	1.576937e-2	1.000000e+0	1.000000e+0	6.341407e+1	1.576937e-2	1	1.576937e-2	1.000000e+0	9	2.040425e-2	1.000000e+0	1.000000e+0	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	FA2H
MSigDB Immunologic Signatures	GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_UP	Genes up-regulated in comparison of naive CD8 T cells versus effector CD8 T cells KLRG1 high [GeneID=10219].	16	1.641226e-2	1.000000e+0	1.000000e+0	6.093004e+1	1.641226e-2	1	1.641226e-2	1.000000e+0	19	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	WDR59
MSigDB Immunologic Signatures	GSE3982_BCELL_VS_TH1_UP	Genes up-regulated in comparison of B cells versus Th1 cells.	17	1.682300e-2	1.000000e+0	1.000000e+0	5.944244e+1	1.682300e-2	1	1.682300e-2	1.000000e+0	12	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	FA2H
MSigDB Immunologic Signatures	GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_DN	Genes down-regulated in comparison of naive B cells versus blood plasma cells.	18	1.703464e-2	1.000000e+0	1.000000e+0	5.870393e+1	1.703464e-2	1	1.703464e-2	1.000000e+0	18	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	FA2H
MSigDB Immunologic Signatures	GSE11057_CD4_CENT_MEM_VS_PBMC_UP	Genes up-regulated in comparison of central memory T cells versus peripheral blood mononuclear cells (PBMC).	19	1.739136e-2	1.000000e+0	1.000000e+0	5.749982e+1	1.739136e-2	1	1.739136e-2	1.000000e+0	8	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	WDR59
MSigDB Immunologic Signatures	GSE3982_BCELL_VS_NKCELL_UP	Genes up-regulated in comparison of B cells versus NK cells.	20	1.844960e-2	1.000000e+0	1.000000e+0	5.420173e+1	1.844960e-2	1	1.844960e-2	1.000000e+0	29	2.215906e-2	1.000000e+0	1.000000e+0	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	FA2H
MSigDB Immunologic Signatures	GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_UP	Genes up-regulated in comparison of B cells versus central memory CD4 [GeneID=920] T cells.	21	1.874942e-2	1.000000e+0	1.000000e+0	5.333499e+1	1.874942e-2	1	1.874942e-2	1.000000e+0	16	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	FA2H
MSigDB Immunologic Signatures	GSE1460_DP_VS_CD4_THYMOCYTE_UP	Genes up-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus T cells from cord blood.	22	1.885849e-2	1.000000e+0	1.000000e+0	5.302651e+1	1.885849e-2	1	1.885849e-2	1.000000e+0	31	2.270712e-2	1.000000e+0	1.000000e+0	4.378883e+1	2.283687e-2	1	206	5.000000e-1	4.854369e-3	unnamed	FA2H
MSigDB Immunologic Signatures	GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_UP	Genes up-regulated in comparison of B cells versus effector memory CD4 [GeneID=920] T cells.	23	1.894110e-2	1.000000e+0	1.000000e+0	5.279523e+1	1.894110e-2	1	1.894110e-2	1.000000e+0	9	2.040425e-2	1.000000e+0	1.000000e+0	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	FA2H
MSigDB Immunologic Signatures	GSE3982_MAST_CELL_VS_DC_DN	Genes down-regulated in comparison of mast cells versus dendritic cells (DC).	24	1.901763e-2	1.000000e+0	1.000000e+0	5.258278e+1	1.901763e-2	1	1.901763e-2	1.000000e+0	30	2.237830e-2	1.000000e+0	1.000000e+0	4.443596e+1	2.250430e-2	1	203	5.000000e-1	4.926108e-3	unnamed	FA2H
MSigDB Immunologic Signatures	GSE22886_NAIVE_TCELL_VS_DC_UP	Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated dendritic cells (DC).	25	1.906824e-2	1.000000e+0	1.000000e+0	5.244322e+1	1.906824e-2	1	1.906824e-2	1.000000e+0	24	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	WDR59
MSigDB Immunologic Signatures	GSE3982_DC_VS_TH2_UP	Genes up-regulated in comparison of dendritic cells (DC) versus Th2 cells.	26	1.929899e-2	1.000000e+0	1.000000e+0	5.181620e+1	1.929899e-2	1	1.929899e-2	1.000000e+0	19	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	FA2H
MSigDB Immunologic Signatures	GSE3982_MAST_CELL_VS_BCELL_DN	Genes down-regulated in comparison of mast cells versus B cells.	27	1.939269e-2	1.000000e+0	1.000000e+0	5.156581e+1	1.939269e-2	1	1.939269e-2	1.000000e+0	9	2.040425e-2	1.000000e+0	1.000000e+0	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	FA2H
MSigDB Immunologic Signatures	GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP	Genes up-regulated in comparison of central memory CD4 [GeneID=920] T cells versus Th2 cells.	28	2.042785e-2	1.000000e+0	1.000000e+0	4.895277e+1	2.042785e-2	1	2.042785e-2	1.000000e+0	16	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	WDR59
MSigDB Immunologic Signatures	GSE27786_NKCELL_VS_NEUTROPHIL_DN	Genes down-regulated in comparison of NK cells versus neutrophils.	29	2.214477e-2	1.000000e+0	1.000000e+0	4.515740e+1	2.214477e-2	1	2.214477e-2	1.000000e+0	12	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	FA2H
MSigDB Immunologic Signatures	GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_DN	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells versus CD8 T cells treated with leukocyte costimulatory blockade antibodies.	30	2.223557e-2	1.000000e+0	1.000000e+0	4.497299e+1	2.223557e-2	1	2.223557e-2	1.000000e+0	26	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	WDR59
MSigDB Immunologic Signatures	GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP	Genes up-regulated in comparison of memory CD4 [GeneID=920] T cells versus Th2 cells.	31	2.340738e-2	1.000000e+0	1.000000e+0	4.272157e+1	2.340738e-2	1	2.340738e-2	1.000000e+0	12	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	WDR59
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
